AXA/2025/FY/Earnings presentation: Difference between revisions
doc_archive: publish snjra2xp9r (.md link) |
doc_archive: publish snjra2xp9r |
||
| Line 10: | Line 10: | ||
| pages = 49 |
| pages = 49 |
||
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf |
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf |
||
| summary_md = |
| summary_md = <!-- ARCHIVE_MD_LINK_HERE --> |
||
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages). |
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages). |
||
| wide = yes |
| wide = yes |
||
| Line 19: | Line 19: | ||
''This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).'' |
''This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).'' |
||
=== Full Year 2025 Earnings Presentation === |
=== Full Year 2025 Earnings Presentation February 26, 2026 === |
||
{{chunk|doc=snjra2xp9r|c=1|p=1}} |
|||
====== Presentation date ====== |
|||
* The presentation date is February 26, [[Definition:Year 2026|2026]]. |
|||
=== Full Year 2025 Earnings === |
=== Full Year 2025 Earnings === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=1|p=2}} |
||
====== Legal and cautionary statements ====== |
====== Legal and cautionary statements ====== |
||
* Certain statements in |
* Certain statements in this document are forward-looking, identified by words like "expects," "anticipates," "may," "plan," "target," "would," and "could". |
||
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] (UEPS) growth for [[Definition:Year 2026|2026]] are forward-looking and provide one-off guidance for the last year of the Group’s current strategic plan. |
|||
* Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", "would", and "could". |
|||
* Forward-looking statements are based on Management’s current views and intentions, are subject to change, and carry known and unknown risks and uncertainties outside AXA’s control that could cause actual results to differ materially. |
|||
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] (UEPS) growth for [[Definition:Year 2026|2026]] are forward-looking statements providing one-off guidance for the last year of the Group’s current strategic plan. |
|||
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by law. |
|||
* These statements are based on Management’s current views and intentions and are subject to change. |
|||
* This presentation refers to non-GAAP financial measures (APMs) used by Management for analyzing operating trends, financial performance, and position. |
|||
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties outside AXA’s control, which can cause actual results to differ materially. |
|||
* Non-GAAP financial measures generally lack standardized meaning and may not be comparable to measures used by other companies. |
|||
* Each forward-looking statement is valid only at the date of the presentation. |
|||
* For important factors, risks, and uncertainties affecting AXA’s business and/or results, refer to Part 5 - “Risk Factors and Risk Management” of AXA’s Universal Registration Document for the year ended December 31, 2024 (the “2024 Universal Registration Document”). |
|||
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations. |
|||
* The presentation refers to non-GAAP financial measures, or alternative performance measures (APMs), used by Management for analyzing operating trends, financial performance, and position. |
|||
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to measures used by other companies. |
|||
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS. |
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS. |
||
* "[[Definition:Underlying earnings|Underlying earnings]]" |
* "[[Definition:Underlying earnings|Underlying earnings]]," UEPS, "underlying return on equity," "combined ratio," and "debt gearing" are APMs as defined by ESMA’s guidelines and AMF’s position statement. |
||
* |
* Reconciliations of APMs to IFRS financial statements and their calculation methodologies are provided in AXA’s 2025 Activity Report. |
||
* AXA’s 2025 Activity Report is available on www.axa.com. |
|||
* Further information on non-GAAP financial measures is available in the Glossary in AXA’s 2025 Activity Report. |
|||
* AXA’s |
* AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to audit completion. |
||
* AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA’s statutory auditors. |
|||
=== Contents === |
|||
{{chunk|doc=snjra2xp9r|c=3|p=3}} |
|||
====== Presentation structure and speakers ====== |
|||
{{chunk|doc=snjra2xp9r|c=2|p=3}} |
|||
* The presentation includes "[[Definition:Full year 2025|FY25]] Highlights" on page 04, presented by Thomas Buberl, Group CEO. |
|||
====== Presentation contents and speakers ====== |
|||
* "FY25 Business Performance" is on page 09, presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology. |
|||
* "FY25 Financial Performance" is on page 13, presented by Alban de Mailly Nesle, Group CFO. |
|||
* [[Definition:Full year 2025|FY25]] Highlights are on p.04. |
|||
* Thomas Buberl is the Group CEO. |
|||
* FY25 Business Performance is on p.09. |
|||
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology. |
|||
* FY25 Financial Performance is on p.13. |
|||
* Alban de Mailly Nesle is the Group CFO. |
|||
== FY25 Highlights == |
== FY25 Highlights == |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=3|p=4}} |
||
====== Group CEO ====== |
====== Group CEO ====== |
||
| Line 64: | Line 59: | ||
=== Full Year 2025 – Excellent performance === |
=== Full Year 2025 – Excellent performance === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=4|p=5}} |
||
====== Financial performance |
====== Financial performance highlights ====== |
||
* Revenues +6% vs. [[Definition:Full year 2024|FY24]] |
* Revenues: +6% vs. [[Definition:Full year 2024|FY24]] |
||
* [[Definition:Underlying earnings per share|Underlying EPS]] +8% vs. FY24 |
* [[Definition:Underlying earnings per share|Underlying EPS]]: +8% vs. FY24 |
||
* ROE 16% [[Definition:Full year 2025|FY25]] |
* ROE: 16% in [[Definition:Full year 2025|FY25]] |
||
* Solvency II ratio 224% FY25 |
* Solvency II ratio: 224% in FY25 |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=5|p=5}} |
||
====== Shareholder returns and |
====== Shareholder returns and outlook ====== |
||
* DPS growth: +8% |
|||
* Delivering value for shareholders with +8% DPS growth and EUR 1.25bn annual [[Definition:Share buyback|share buyback]] |
|||
* Annual [[Definition:Share buyback|share buyback]]: EUR 1.25bn |
|||
* Confident to deliver [[Definition:Underlying earnings per share|underlying EPS]] growth at the upper end of the 6%-8% [[Definition:Target range|target range]] for [[Definition:Year 2026|2026]] |
* Confident to deliver [[Definition:Underlying earnings per share|underlying EPS]] growth at the upper end of the 6%-8% [[Definition:Target range|target range]] for [[Definition:Year 2026|2026]] |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=6|p=5}} |
||
====== Full Year 2025 – Excellent performance ====== |
====== Full Year 2025 – Excellent performance ====== |
||
| Line 86: | Line 82: | ||
=== Executing the plan on growth, margin and efficiency === |
=== Executing the plan on growth, margin and efficiency === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=7|p=6}} |
||
====== Underlying earnings by |
====== Underlying earnings by FY ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 108: | Line 104: | ||
|} |
|} |
||
</div> |
</div> |
||
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) |
|||
{{chunk|doc=snjra2xp9r|c=8|p=6}} |
|||
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency |
|||
====== Organic growth, profitability, and efficiency ====== |
|||
* Scaling the business: Continued investments in growth and technology |
|||
* Consistent earnings growth while enhancing reserve prudence |
|||
* Top line growth: +6% organic. |
|||
* Growth balanced across lines: P&C +5%, Life +9%, Health +5%. |
|||
* Record profitability with further margin expansion in P&C and L&H. |
|||
* Improved efficiency. |
|||
* Continued investments in growth and technology for scaling the business. |
|||
* Consistent earnings growth while enhancing reserve prudence. |
|||
{{chunk|doc=snjra2xp9r|c=9|p=6}} |
|||
====== Executing the plan on growth, margin and efficiency ====== |
|||
{{fn note|1=1|2=Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.}} |
{{fn note|1=1|2=Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.}} |
||
| Line 119: | Line 124: | ||
==== Secular trends fueling demand across businesses ==== |
==== Secular trends fueling demand across businesses ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=10|p=7}} |
||
====== Protection gaps and emerging risks ====== |
|||
* Protection gaps and emerging corporate risks are secular trends fueling demand across businesses. |
|||
* Demographics are driving demand for private retirement and healthcare. |
|||
{{chunk|doc=snjra2xp9r|c=11|p=7}} |
|||
====== Share by segment ====== |
====== Share by segment ====== |
||
| Line 136: | Line 147: | ||
| style="text-align:left" | Large & Specialty |
| style="text-align:left" | Large & Specialty |
||
| style="text-align:right" | 17% |
| style="text-align:right" | 17% |
||
|- |
|||
| style="text-align:left" | SME & Mid-market |
|||
| style="text-align:right" | 16% |
|||
|- |
|- |
||
| style="text-align:left" | Retail |
| style="text-align:left" | Retail |
||
| style="text-align:right" | 17% |
| style="text-align:right" | 17% |
||
|- |
|||
| style="text-align:left" | SME & Mid-market |
|||
| style="text-align:right" | 16% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=12|p=7}} |
||
====== Secular trends fueling demand ====== |
====== Secular trends fueling demand ====== |
||
* Secular trends are fueling demand across businesses. |
|||
* Protection gaps and emerging corporate risks are driving demand. |
|||
* Demographics are driving demand for private retirement and healthcare. |
|||
==== Our right to win ==== |
==== Our right to win ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=13|p=7}} |
||
====== |
====== Right to win ====== |
||
* Leading brand and high customer NPS |
* Leading brand and high customer NPS |
||
* Strong and diversified distribution |
* Strong and diversified distribution |
||
* Technical expertise in pricing and underwriting risks |
* Technical expertise in pricing and underwriting risks |
||
* Scale offering cost advantage |
* Scale offering a cost advantage |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=14|p=7}} |
||
====== Our right to win ====== |
====== Our right to win ====== |
||
| Line 168: | Line 178: | ||
=== Laying the foundation for the next plan === |
=== Laying the foundation for the next plan === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=15|p=8}} |
||
====== Strategic priorities ====== |
====== Strategic priorities ====== |
||
| Line 179: | Line 189: | ||
== FY25 Business Performance == |
== FY25 Business Performance == |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=16|p=9}} |
||
====== |
====== FY25 Business Performance ====== |
||
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology. |
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology. |
||
| Line 186: | Line 196: | ||
=== Strong delivery across our businesses === |
=== Strong delivery across our businesses === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=17|p=10}} |
||
====== Gross written premiums & Underlying earnings by geography ====== |
====== Gross written premiums & Underlying earnings by geography ====== |
||
| Line 195: | Line 205: | ||
! style="text-align:right" | Gross written premiums |
! style="text-align:right" | Gross written premiums |
||
! style="text-align:right" | Underlying earnings |
! style="text-align:right" | Underlying earnings |
||
|- |
|||
| style="text-align:left" | France (27% of total GWP{{fn ref|1}}) |
|||
| style="text-align:right" | +6% to €31bn |
|||
| style="text-align:right" | +7% to €2.2bn |
|||
|- |
|||
| style="text-align:left" | Europe (38% of total GWP{{fn ref|1}}) |
|||
| style="text-align:right" | +6% to €43bn |
|||
| style="text-align:right" | +9% to €3.5bn |
|||
|- |
|||
| style="text-align:left" | AXA XL (17% of total GWP{{fn ref|1}}) |
|||
| style="text-align:right" | +4% to €19bn |
|||
| style="text-align:right" | +9% to €1.9bn |
|||
|- |
|||
| style="text-align:left" | Asia, Africa & EME-LATAM (18% of total GWP{{fn ref|1}}) |
|||
| style="text-align:right" | +13% to €20bn |
|||
| style="text-align:right" | +6% to €1.5bn |
|||
|} |
|} |
||
</div> |
</div> |
||
<tr><td>France (27% of total [[Definition:Gross written premiums|GWP]]{{fn ref|1}})</td><td>+6% to €31bn</td><td>+7% to €2.2bn</td></tr> |
|||
<tr><td>Europe (38% of total GWP{{fn ref|1}})</td><td>+6% to €43bn</td><td>+9% to €3.5bn</td></tr> |
|||
<tr><td>AXA XL (17% of total GWP{{fn ref|1}})</td><td>+4% to €19bn</td><td>+9% to €1.9bn</td></tr> |
|||
<tr><td>Asia, Africa & EME-LATAM (18% of total GWP{{fn ref|1}})</td><td>+13% to €20bn</td><td>+6% to €1.5bn</td></tr> |
|||
</table> |
|||
{{fn note|1=1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}} |
{{fn note|1=1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}} |
||
| Line 207: | Line 228: | ||
=== P&C – Strong margins, confidence in sustaining growth === |
=== P&C – Strong margins, confidence in sustaining growth === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=18|p=11}} |
||
====== |
====== P&C GWP and earnings ====== |
||
* [[Definition:Gross written premiums| |
* [[Definition:Gross written premiums|GWP]]: EUR 58bn |
||
* GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty) |
* GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty) |
||
* [[Definition:Underlying earnings|Underlying earnings]]: +9% to EUR 5.9bn |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=19|p=11}} |
||
====== |
====== Outlook by business segment ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 233: | Line 255: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=20|p=11}} |
||
====== |
====== Future strategic focus ====== |
||
* [[Definition:Underlying earnings|Underlying earnings]]: +9% to EUR 5.9bn |
|||
* Continued progress on efficiency |
* Continued progress on efficiency |
||
* Higher investment income |
* Higher investment income |
||
* Data & AI to further enhance customer experience & technical excellence |
* Data & AI to further enhance customer experience & technical excellence |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=21|p=11}} |
||
====== P&C – Strong margins, confidence in sustaining growth ====== |
====== P&C – Strong margins, confidence in sustaining growth ====== |
||
| Line 249: | Line 270: | ||
=== L&H – Good momentum, well positioned to capture growth opportunities === |
=== L&H – Good momentum, well positioned to capture growth opportunities === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=22|p=12}} |
||
====== GWP by |
====== GWP by short-term and long-term ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 256: | Line 277: | ||
|- |
|- |
||
| style="text-align:left" | Short-term |
| style="text-align:left" | Short-term |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
|- |
|||
| style="text-align:left" | Long-term |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Total GWP |
|||
| style="text-align:right" | €57bn |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=23|p=12}} |
|||
====== Underlying earnings ====== |
|||
* [[Definition:Underlying earnings|Underlying earnings]] +7% to EUR 3.5bn |
|||
==== 2025 Beyond 2025 ==== |
==== 2025 Beyond 2025 ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=24|p=12}} |
||
====== Strategic priorities |
====== Strategic priorities ====== |
||
* Long-term business: |
* Long-term business: Accelerating net flows in Savings at attractive margins. |
||
* Long-term business: Capturing savings & retirement opportunity, sourcing best asset management products for customers. |
|||
** 2025: Accelerating net flows in Savings at attractive margins |
|||
* Short-term business: Growing technical results while absorbing Mexico VAT impact. |
|||
** Beyond 2025: Capturing savings & retirement opportunity, sourcing best asset management products for customers |
|||
* Short-term business: |
* Short-term business: Capitalizing on demand for health & protection while further improving margins. |
||
* Focus on cost reduction. |
|||
** 2025: Growing technical results while absorbing Mexico VAT impact |
|||
* Increasing penetration of Protection riders in Savings offerings. |
|||
** Beyond 2025: Capitalizing on demand for health & protection while further improving margins |
|||
* Leveraging AI to reduce claims leakage & improve customer outcomes in Health. |
|||
* [[Definition:Underlying earnings|Underlying earnings]] +7% to EUR 3.5bn |
|||
* Focus on cost reduction |
|||
* Increasing penetration of Protection riders in Savings offerings |
|||
* Leveraging AI to reduce claims leakage & improve customer outcomes in Health |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=25|p=12}} |
||
====== 2025 Beyond 2025 ====== |
====== 2025 Beyond 2025 ====== |
||
{{fn note|1=1|2=Change FY25 vs. FY24 at constant FX.}} |
{{fn note|1=1|2=1. Change FY25 vs. FY24 at constant FX.}} |
||
== FY25 Financial Performance == |
== FY25 Financial Performance == |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=26|p=13}} |
||
====== Group CFO ====== |
====== Group CFO ====== |
||
| Line 290: | Line 319: | ||
=== P&C – Continued disciplined growth === |
=== P&C – Continued disciplined growth === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=27|p=14}} |
||
====== Currency notation ====== |
====== Currency notation ====== |
||
| Line 297: | Line 326: | ||
==== GWP & Other Revenues ==== |
==== GWP & Other Revenues ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=28|p=14}} |
||
====== GWP & other revenues by |
====== GWP & other revenues by segment ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id="t6" class="wikitable fintable" |
{| id="t6" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Segment |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
| Line 311: | Line 340: | ||
|- |
|- |
||
| style="text-align:left" | Commercial lines |
| style="text-align:left" | Commercial lines |
||
| |
| style="text-align:right" | |
||
| style="text-align:right" | 35.8 |
| style="text-align:right" | 35.8 |
||
| style="text-align:right" | +4% |
| style="text-align:right" | +4% |
||
| Line 318: | Line 347: | ||
|- |
|- |
||
| style="text-align:left" | AXA XL Reinsurance |
| style="text-align:left" | AXA XL Reinsurance |
||
| style="text-align:right" | |
|||
| style="text-align:right" | 2.6 |
| style="text-align:right" | 2.6 |
||
| style="text-align:right" | +8% |
| style="text-align:right" | +8% |
||
| Line 324: | Line 354: | ||
|- |
|- |
||
| style="text-align:left" | Retail lines |
| style="text-align:left" | Retail lines |
||
| style="text-align:right" | |
|||
| style="text-align:right" | 19.7 |
| style="text-align:right" | 19.7 |
||
| style="text-align:right" | +7% |
| style="text-align:right" | +7% |
||
| Line 338: | Line 369: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=29|p=14}} |
||
====== Commercial lines growth drivers ====== |
====== Commercial lines growth drivers ====== |
||
* Continued pricing momentum and volume growth in Mid-market and SME |
* Continued pricing momentum and volume growth in Mid-market and SME |
||
* Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance |
* Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance |
||
* Growth supported by alternative capital |
* Growth supported by alternative capital |
||
* Favorable pricing trends and strong growth in net new contracts (+1.7m in [[Definition:Full year 2025|FY25]]) |
* Favorable pricing trends and strong growth in net new contracts (+1.7m in [[Definition:Full year 2025|FY25]]) |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=30|p=14}} |
||
====== GWP & Other Revenues ====== |
====== GWP & Other Revenues ====== |
||
| Line 356: | Line 387: | ||
==== Combined ratio ==== |
==== Combined ratio ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=31|p=15}} |
||
====== Combined ratio ====== |
====== Combined ratio ====== |
||
| Line 366: | Line 397: | ||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Combined ratio |
| style="text-align:left" | Combined ratio |
||
| style="text-align:right" | 91.0% |
| style="text-align:right" | 91.0% |
||
| style="text-align:right" | 90.6% |
| style="text-align:right" | 90.6% |
||
| Line 392: | Line 423: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=32|p=15}} |
||
====== Combined ratio drivers ====== |
====== Combined ratio drivers ====== |
||
* Undiscounted current year loss ratio improved, excluding Nat Cat. |
* Undiscounted current year loss ratio improved, excluding Nat Cat. |
||
* Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing. |
* Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing. |
||
* AXA XL Insurance margins stable at attractive levels |
* AXA XL Insurance margins stable at attractive levels due to disciplined cycle management. |
||
* Expense ratio improved due to efficiency measures, while |
* Expense ratio improved due to efficiency measures, while investing in growth initiatives and technology. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=33|p=15}} |
||
====== Nat Cat and reserve |
====== Nat Cat and reserve development ====== |
||
* Nat Cat charges were below the normalized load. |
* Nat Cat charges were below the normalized load. |
||
| Line 409: | Line 440: | ||
=== P&C – Earnings growth from higher underwriting and financial result === |
=== P&C – Earnings growth from higher underwriting and financial result === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=34|p=16}} |
||
====== P&C earnings |
====== P&C earnings overview ====== |
||
* P&C earnings |
* P&C earnings increased by EUR 0.2bn to EUR 4.2bn. |
||
* This growth was driven by |
* This growth was driven by higher underwriting results and a higher financial result. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=35|p=16}} |
||
====== Underlying earnings |
====== Underlying earnings by step ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 427: | Line 458: | ||
| style="text-align:right" | 5,510 |
| style="text-align:right" | 5,510 |
||
|- |
|- |
||
| style="text-align:left" | Volume growth |
| style="text-align:left" | Volume growth ( Underwriting result{{fn ref|1}}) |
||
| style="text-align:right" | +292 |
| style="text-align:right" | +292 |
||
|- |
|- |
||
| Line 433: | Line 464: | ||
| style="text-align:right" | +189 |
| style="text-align:right" | +189 |
||
|- |
|- |
||
| style="text-align:left" | Investment income |
| style="text-align:left" | Investment income ( Financial result) |
||
| style="text-align:right" | +435 |
| style="text-align:right" | +435 |
||
|- |
|- |
||
| style="text-align:left" | Insurance |
| style="text-align:left" | Insurance finance expenses |
||
| style="text-align:right" | -235 |
| style="text-align:right" | -235 |
||
|- |
|- |
||
| Line 450: | Line 481: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=36|p=16}} |
||
====== P&C earnings growth ====== |
====== P&C earnings growth drivers ====== |
||
* P&C earnings grew +9%. |
* P&C earnings grew +9%. |
||
* Growth |
* Growth driven by a better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence. |
||
* Increase in investment income reflects higher volumes and better reinvestment yields on fixed income assets. |
|||
* Growth was driven by the financial result. |
|||
* Higher unwind of discount of claims reserves, in line with guidance. |
|||
* Unfavorable forex impact notably due to USD depreciation vs. EUR. |
|||
{{chunk|doc=snjra2xp9r|c=34|p=16}} |
|||
====== Underwriting result drivers ====== |
|||
* The underwriting result improved due to strong volume growth. |
|||
* The underwriting result improved due to an enhanced all-year combined ratio. |
|||
* The underwriting result improved while enhancing reserve prudence. |
|||
{{chunk|doc=snjra2xp9r|c=35|p=16}} |
|||
====== Financial result drivers ====== |
|||
* Investment income increased due to higher volumes. |
|||
* Investment income increased due to better reinvestment yields on fixed income assets. |
|||
* The unwind of discount of claims reserves was higher, in line with guidance. |
|||
{{chunk|doc=snjra2xp9r|c=36|p=16}} |
|||
====== Forex impact ====== |
|||
* There was an unfavorable forex impact, notably due to USD depreciation vs. EUR. |
|||
{{chunk|doc=snjra2xp9r|c=37|p=16}} |
{{chunk|doc=snjra2xp9r|c=37|p=16}} |
||
====== P&C – Earnings growth from higher underwriting and financial result ====== |
====== P&C – Earnings growth from higher underwriting and financial result ====== |
||
{{fn note|1=1|2= |
{{fn note|1=1|2=Underwriting result includes expenses.}} |
||
=== Life & Health – Strong growth in premiums, positive net flows === |
=== Life & Health – Strong growth in premiums, positive net flows === |
||
{{chunk|doc=snjra2xp9r|c=38|p=17}} |
{{chunk|doc=snjra2xp9r|c=38|p=17}} |
||
====== Life |
====== Life & Health premiums and net flows ====== |
||
* Life & Health premiums: EUR 49.1bn (+7% LFL) |
|||
* Life & Health net flows: EUR +0.2bn |
|||
{{chunk|doc=snjra2xp9r|c=39|p=17}} |
|||
====== Life GWP & other revenues by lines of business ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 493: | Line 513: | ||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Growth |
! class="col-s" style="text-align:right" | Growth |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 34.5 |
|||
| style="text-align:right" | 37.5 |
|||
| style="text-align:right" | +9% |
|||
|- |
|- |
||
| style="text-align:left" | Protection |
| style="text-align:left" | Protection |
||
| Line 513: | Line 538: | ||
| style="text-align:right" | 1.9 |
| style="text-align:right" | 1.9 |
||
| style="text-align:right" | -7% |
| style="text-align:right" | -7% |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 34.5 |
|||
| style="text-align:right" | 37.5 |
|||
| style="text-align:right" | +9% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=40|p=17}} |
||
====== Health GWP & other revenues by individual and group ====== |
====== Health GWP & other revenues by individual and group ====== |
||
| Line 531: | Line 551: | ||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Growth |
! class="col-s" style="text-align:right" | Growth |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 17.5 |
|||
| style="text-align:right" | 19.0 |
|||
| style="text-align:right" | +5% |
|||
|- |
|- |
||
| style="text-align:left" | Individual |
| style="text-align:left" | Individual |
||
| Line 541: | Line 566: | ||
| style="text-align:right" | 8.5 |
| style="text-align:right" | 8.5 |
||
| style="text-align:right" | +4% |
| style="text-align:right" | +4% |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 17.5 |
|||
| style="text-align:right" | 19.0 |
|||
| style="text-align:right" | +5% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=41|p=17}} |
||
====== |
====== Net flows by segment ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 556: | Line 576: | ||
|- |
|- |
||
! style="text-align:left" | Segment |
! style="text-align:left" | Segment |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Net flows |
||
|- |
|- |
||
| style="text-align:left" | Protection |
| style="text-align:left" | Protection |
||
| Line 575: | Line 595: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=42|p=17}} |
||
====== Employee Benefits premiums ====== |
====== Employee Benefits premiums ====== |
||
* Employee Benefits premiums: EUR 12.9bn (+4% vs. [[Definition:Full year 2024|FY24]]) |
* Employee Benefits premiums: EUR 12.9bn (+4% vs. [[Definition:Full year 2024|FY24]]) at constant scope and [[Definition:Foreign exchange|FX]]. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=43|p=17}} |
||
====== Life & Health – Strong growth in premiums, positive net flows ====== |
====== Life & Health – Strong growth in premiums, positive net flows ====== |
||
{{fn note|1=1|2= |
{{fn note|1=1|2=Including both short-term and long-term Employee Benefits GWP and other revenues.}} |
||
=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
||
{{chunk|doc=snjra2xp9r|c=43|p=18}} |
|||
====== Currency notation ====== |
|||
* All figures are in EUR billion. |
|||
{{chunk|doc=snjra2xp9r|c=44|p=18}} |
{{chunk|doc=snjra2xp9r|c=44|p=18}} |
||
====== PVEP by business |
====== PVEP by business line ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 603: | Line 618: | ||
|- |
|- |
||
| style="text-align:left" | Protection & Health |
| style="text-align:left" | Protection & Health |
||
| |
| style="text-align:right" | |
||
| style="text-align:right" | 31.4 |
| style="text-align:right" | 31.4 |
||
|- |
|- |
||
| style="text-align:left" | Unit-Linked |
| style="text-align:left" | Unit-Linked |
||
| style="text-align:right" | |
|||
| style="text-align:right" | 8.5 |
| style="text-align:right" | 8.5 |
||
|- |
|- |
||
| style="text-align:left" | Capital-light G/A |
| style="text-align:left" | Capital-light G/A |
||
| style="text-align:right" | |
|||
| style="text-align:right" | 7.8 |
| style="text-align:right" | 7.8 |
||
|- |
|- |
||
| style="text-align:left" | Traditional G/A |
| style="text-align:left" | Traditional G/A |
||
| style="text-align:right" | |
|||
| style="text-align:right" | 1.7 |
| style="text-align:right" | 1.7 |
||
|- |
|- |
||
| Line 620: | Line 638: | ||
|- |
|- |
||
| style="text-align:left" | Change |
| style="text-align:left" | Change |
||
| style="text-align:right" | |
| colspan="2" style="text-align:right" | -2% |
||
| style="text-align:right" | -2% |
|||
|- |
|- |
||
| style="text-align:left" | Protection & Health change |
| style="text-align:left" | Protection & Health change |
||
| style="text-align:right" | |
| colspan="2" style="text-align:right" | -4% |
||
| style="text-align:right" | -4% |
|||
|- |
|- |
||
| style="text-align:left" | Unit-Linked change |
| style="text-align:left" | Unit-Linked change |
||
| style="text-align:right" | |
| colspan="2" style="text-align:right" | +18% |
||
| style="text-align:right" | +18% |
|||
|- |
|- |
||
| style="text-align:left" | Capital-light G/A change |
| style="text-align:left" | Capital-light G/A change |
||
| style="text-align:right" | |
| colspan="2" style="text-align:right" | -10% |
||
| style="text-align:right" | -10% |
|||
|- |
|- |
||
| style="text-align:left" | Traditional G/A change |
| style="text-align:left" | Traditional G/A change |
||
| style="text-align:right" | |
| colspan="2" style="text-align:right" | -10% |
||
| style="text-align:right" | -10% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=45|p=18}} |
{{chunk|doc=snjra2xp9r|c=45|p=18}} |
||
====== NB CSM (pre-tax) ====== |
====== NB CSM (pre-tax) by FY ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id="t13" class="wikitable fintable" |
{| id="t13" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | FY24 |
||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2.2 |
||
| style="text-align:right" | 2.2 |
|||
| style="text-align:right" | 2.2 |
| style="text-align:right" | 2.2 |
||
|- |
|- |
||
| style="text-align:left" | |
| colspan="2" style="text-align:left" | +3% |
||
| style="text-align:right" | |
|||
| style="text-align:right" | +3% |
|||
|} |
|} |
||
</div> |
</div> |
||
| Line 667: | Line 676: | ||
{| id="t14" class="wikitable fintable" |
{| id="t14" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | FY24 |
||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2.3 |
||
| style="text-align:right" | 2.3 |
|||
| style="text-align:right" | 2.2 |
| style="text-align:right" | 2.2 |
||
|- |
|- |
||
| style="text-align:left" | |
| colspan="2" style="text-align:left" | stable |
||
| style="text-align:right" | |
|||
| style="text-align:right" | stable |
|||
|- |
|- |
||
| style="text-align:left" | NBV margin |
| style="text-align:left" | NBV margin 4.4% |
||
| style="text-align:right" | 4.4% |
|||
| style="text-align:right" | 4.5% |
| style="text-align:right" | 4.5% |
||
|} |
|} |
||
| Line 686: | Line 690: | ||
{{chunk|doc=snjra2xp9r|c=47|p=18}} |
{{chunk|doc=snjra2xp9r|c=47|p=18}} |
||
====== |
====== Life & Health performance drivers ====== |
||
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes. |
* PVEP was impacted by higher interest rates on discounting, despite strong growth in Life volumes. |
||
* NB CSM was driven by robust Savings & Protection sales |
* NB CSM was driven by robust Savings & Protection sales; reported growth was impacted by higher interest rates for discounting of future profits. |
||
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France. |
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France. |
||
{{chunk|doc=snjra2xp9r|c=48|p=18}} |
{{chunk|doc=snjra2xp9r|c=48|p=18}} |
||
====== Reporting basis ====== |
|||
====== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ====== |
|||
* All changes are at constant scope and [[Definition:Foreign exchange|FX]]. |
|||
=== Life & Health – Growth in new business driving Normalized CSM growth === |
=== Life & Health – Growth in new business driving Normalized CSM growth === |
||
{{chunk|doc=snjra2xp9r|c=49|p=19}} |
{{chunk|doc=snjra2xp9r|c=49|p=19}} |
||
====== |
====== Financial Metrics ====== |
||
* |
* All figures are in EUR billion. |
||
==== Contractual Service Margin rollforward ==== |
==== Contractual Service Margin rollforward ==== |
||
| Line 720: | Line 724: | ||
! style="text-align:right" | Affiliates, FX & other |
! style="text-align:right" | Affiliates, FX & other |
||
! style="text-align:right" | FY25 |
! style="text-align:right" | FY25 |
||
|- |
|||
| style="text-align:left" | 33.6 |
|||
| style="text-align:right" | +2.2 |
|||
| style="text-align:left" | +1.3 |
|||
| style="text-align:right" | -3.0 |
|||
| style="text-align:right" | +0.6 |
|||
| style="text-align:right" | -0.3 |
|||
| style="text-align:right" | -1.4 |
|||
| style="text-align:right" | 33.0 |
|||
|- |
|||
| colspan="8" style="text-align:left" | Normalized CSM growth +2% |
|||
|} |
|} |
||
</div> |
</div> |
||
<tr><td>33.6</td><td>+2.2</td><td>+1.3</td><td>-3.0</td><td>+0.6</td><td>-0.3</td><td>-1.4</td><td>33.0</td></tr> |
|||
<tr><td>o/w Life: 25.8</td><td></td><td></td><td></td><td></td><td></td><td></td><td>25.4</td></tr> |
|||
<tr><td>o/w Health: 7.7</td><td></td><td></td><td></td><td></td><td></td><td></td><td>7.6</td></tr> |
|||
</table> |
|||
{{chunk|doc=snjra2xp9r|c=51|p=19}} |
{{chunk|doc=snjra2xp9r|c=51|p=19}} |
||
====== CSM breakdown by business line ====== |
|||
* Life CSM: EUR 25.4bn ([[Definition:Full year 2025|FY25]]) vs EUR 25.8bn ([[Definition:Full year 2024|FY24]]) |
|||
* Health CSM: EUR 7.6bn (FY25) vs EUR 7.7bn (FY24) |
|||
{{chunk|doc=snjra2xp9r|c=52|p=19}} |
|||
====== Normalized CSM growth and drivers ====== |
====== Normalized CSM growth and drivers ====== |
||
* Normalized CSM |
* Normalized CSM increased by +2% |
||
* |
* CSM release growth reflects better margins |
||
* New business CSM growth impacted by higher rates |
* New business CSM growth was impacted by higher rates |
||
* Economic variance reflects government spreads tightening and positive equity market returns |
* Economic variance reflects government spreads tightening and positive equity market returns |
||
* Operating variance driven by better margins and net flows, |
* Operating variance driven by better margins and net flows, offset by a reduction in the duration of Group Life business in Switzerland |
||
* [[Definition:Foreign exchange|FX]] impact mainly from JPY and HKD depreciation |
* [[Definition:Foreign exchange|FX]] impact mainly from JPY and HKD depreciation |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=53|p=19}} |
||
====== Contractual Service Margin rollforward ====== |
====== Contractual Service Margin rollforward ====== |
||
| Line 744: | Line 761: | ||
=== Life & Health – Strong momentum in both short-term and long-term business === |
=== Life & Health – Strong momentum in both short-term and long-term business === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=54|p=20}} |
||
====== Life & Health |
====== Life & Health gross revenues ====== |
||
* Gross revenues: EUR 32,009m in 2023 (reported) |
|||
* All figures are in EUR million. |
|||
** France: EUR 10,009m |
|||
** Europe: EUR 10,009m |
|||
** AXA XL: EUR 1,000m |
|||
** International: EUR 1,000m |
|||
** Asia: EUR 10,000m |
|||
** Other: EUR 0m |
|||
==== Underlying Earnings ==== |
==== Underlying Earnings +7% ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=55|p=20}} |
||
====== Underlying Earnings |
====== Underlying Earnings waterfall by Step ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id="t16" class="wikitable fintable" |
{| id="t16" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Step |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Value |
||
|- |
|||
! style="text-align:left" | Short-term technical margin |
|||
| style="text-align:left" | FY24 |
|||
| style="text-align:right" | 3,323 |
|||
! class="col-s" style="text-align:right" | Tax, FX and others |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|- |
||
| style="text-align:left" | Short-term technical margin |
| style="text-align:left" | Short-term technical margin |
||
| style="text-align:right" | |
| style="text-align:right" | +60 |
||
| style="text-align:left" | +60 |
|||
| style="text-align:left" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 479 |
|||
|- |
|- |
||
| style="text-align:left" | Long-term result incl. CSM release |
| style="text-align:left" | Long-term result incl. CSM release |
||
| style="text-align:right" | |
| style="text-align:right" | +156 |
||
| style="text-align:left" | |
|||
| style="text-align:left" | +156 |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 2,804 |
|||
|- |
|- |
||
| style="text-align:left" | Financial result |
| style="text-align:left" | Financial result |
||
| style="text-align:right" | 975 |
|||
| style="text-align:left" | |
|||
| style="text-align:left" | |
|||
| style="text-align:right" | -11 |
| style="text-align:right" | -11 |
||
| style="text-align:right" | |
|||
| style="text-align:right" | 946 |
|||
|- |
|- |
||
| style="text-align:left" | Tax |
| style="text-align:left" | Tax, FX and others |
||
| style="text-align:right" | -748 |
|||
| style="text-align:left" | |
|||
| style="text-align:left" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | -27 |
| style="text-align:right" | -27 |
||
| style="text-align:right" | -728 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | FY25 |
||
| style="text-align:right" | 3,323 |
|||
| style="text-align:left" | |
|||
| style="text-align:left" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 3,501 |
| style="text-align:right" | 3,501 |
||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=55|p=20}} |
|||
====== Underlying Earnings ====== |
|||
* [[Definition:Underlying earnings|Underlying Earnings]]: +7% |
|||
{{chunk|doc=snjra2xp9r|c=56|p=20}} |
{{chunk|doc=snjra2xp9r|c=56|p=20}} |
||
====== |
====== FY24 vs FY25 Underlying Earnings breakdown (In Euro million) ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 821: | Line 812: | ||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-m" style="text-align:right" | Change at constant FX |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Short-term technical margin |
||
| style="text-align:right" | |
| style="text-align:right" | 415 |
||
| style="text-align:right" | |
| style="text-align:right" | 479 |
||
| style="text-align:right" | +4% vs. FY24 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Long-term result incl. CSM release |
||
| style="text-align:right" | |
| style="text-align:right" | 2,680 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,804 |
||
|- |
|||
| style="text-align:right" | +17% vs. FY24 |
|||
| style="text-align:left" | Financial result |
|||
| style="text-align:right" | 975 |
|||
| style="text-align:right" | 946 |
|||
|- |
|||
| style="text-align:left" | Tax & others |
|||
| style="text-align:right" | -748 |
|||
| style="text-align:right" | -728 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=57|p=20}} |
{{chunk|doc=snjra2xp9r|c=57|p=20}} |
||
====== |
====== Underlying Earnings by Business Line ====== |
||
* Life [[Definition:Underlying earnings|underlying earnings]]: EUR 2.7bn (prior: EUR 2.6bn), +4% vs. [[Definition:Full year 2024|FY24]] |
|||
* Short-term technical margin was strong, reflecting underwriting and claims initiatives. |
|||
* Health underlying earnings: EUR 0.8bn (prior: EUR 0.7bn), +17% vs. FY24 |
|||
* Underwriting and claims initiatives more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn). |
|||
* Long-term results were higher due to an increase in CSM release (+8%). |
|||
* The increase in CSM release reflects growth in the reserve base, including from favorable equity market performance, and better margins. |
|||
{{chunk|doc=snjra2xp9r|c=58|p=20}} |
{{chunk|doc=snjra2xp9r|c=58|p=20}} |
||
====== |
====== Technical Margin and Long-Term Results ====== |
||
* Strong short-term technical margin due to underwriting and claims initiatives |
|||
* Impact of legislative change on recoverability of value added tax in Mexico: -EUR 0.1bn |
|||
* Higher long-term results from +8% increase in CSM release |
|||
* Increase in CSM release reflects growth in reserve base, including from favorable equity market performance, and better margins |
|||
{{chunk|doc=snjra2xp9r|c=59|p=20}} |
|||
====== Underlying Earnings +7% ====== |
|||
{{fn note|1=1|2=Change at constant FX.}} |
{{fn note|1=1|2=Change at constant FX.}} |
||
| Line 850: | Line 852: | ||
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM === |
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=60|p=21}} |
||
====== Net income by business line ====== |
====== Net income by business line ====== |
||
| Line 908: | Line 910: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=61|p=21}} |
||
====== Underlying earnings and |
====== Underlying earnings and holding costs ====== |
||
* [[Definition:Underlying earnings|Underlying earnings]] showed strong performance from insurance businesses. |
* [[Definition:Underlying earnings|Underlying earnings]] showed strong performance from insurance businesses. |
||
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]]. |
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]]. |
||
* Net income was higher, mainly reflecting higher underlying earnings and the gain from the sale of [[Definition:AXA Investment Managers|AXA IM]]. |
|||
{{chunk|doc=snjra2xp9r|c=62|p=21}} |
|||
====== Net income drivers ====== |
|||
* Net Income was higher, mainly reflecting higher [[Definition:Underlying earnings|underlying earnings]] and the gain from the sale of [[Definition:AXA Investment Managers|AXA IM]]. |
|||
* Lower financial flows reflected an unfavorable forex impact. |
* Lower financial flows reflected an unfavorable forex impact. |
||
==== Underlying earnings per share ==== |
==== Underlying earnings per share ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=63|p=21}} |
||
====== Underlying earnings per share ====== |
====== Underlying earnings per share ====== |
||
* [[Definition:Underlying earnings per share|Underlying earnings per share]] are presented in |
* [[Definition:Underlying earnings per share|Underlying earnings per share]] are presented in EUR. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=64|p=21}} |
||
====== Underlying earnings per share (In Euro) ====== |
====== Underlying earnings per share (In Euro) ====== |
||
| Line 939: | Line 945: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=65|p=21}} |
||
====== Underlying EPS growth drivers ====== |
====== Underlying EPS growth drivers ====== |
||
* [[Definition:Underlying earnings per share|Underlying EPS]] growth |
* [[Definition:Underlying earnings per share|Underlying EPS]] growth included +6% from earnings growth. |
||
* Underlying EPS growth |
* Underlying EPS growth included +3% from [[Definition:Capital management|capital management]]. |
||
* Underlying EPS growth |
* Underlying EPS growth included -2% from forex. |
||
* Underlying EPS growth |
* Underlying EPS growth included -1% from temporary [[Definition:Earnings dilution|earnings dilution]] due to the timing of the anti-dilutive [[Definition:Share buyback|share buyback]] related to the [[Definition:AXA Investment Managers|AXA IM]] sale. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=66|p=21}} |
||
====== Underlying earnings per share ====== |
====== Underlying earnings per share ====== |
||
| Line 953: | Line 959: | ||
=== Shareholders' Equity === |
=== Shareholders' Equity === |
||
{{chunk|doc=snjra2xp9r|c=67|p=22}} |
|||
====== Shareholders' Equity ====== |
|||
* Shareholders' Equity is presented in EUR billion. |
|||
==== Shareholders' equity ==== |
==== Shareholders' equity ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=68|p=22}} |
||
====== Shareholders' equity |
====== Shareholders' equity ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 966: | Line 977: | ||
! class="col-s" style="text-align:right" | HY25 |
! class="col-s" style="text-align:right" | HY25 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 49.9 |
|||
| style="text-align:right" | 45.5 |
|||
| style="text-align:right" | 47.2 |
|||
|- |
|- |
||
| style="text-align:left" | SHE (excl. OCI) |
| style="text-align:left" | SHE (excl. OCI) |
||
| Line 981: | Line 987: | ||
| style="text-align:right" | -7.2 |
| style="text-align:right" | -7.2 |
||
| style="text-align:right" | -6.8 |
| style="text-align:right" | -6.8 |
||
|- |
|||
| style="text-align:left" | Shareholders' Equity |
|||
| style="text-align:right" | 49.9 |
|||
| style="text-align:right" | 45.5 |
|||
| style="text-align:right" | 47.2 |
|||
|- |
|- |
||
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt) |
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt) |
||
| Line 999: | Line 1,010: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=69|p=22}} |
||
====== Shareholders' equity ====== |
====== Shareholders' equity ====== |
||
| Line 1,055: | Line 1,066: | ||
=== Higher organic cash remittance and robust cash position at Holding === |
=== Higher organic cash remittance and robust cash position at Holding === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=70|p=23}} |
||
====== |
====== Currency notation ====== |
||
* |
* All figures are in EUR bn. |
||
==== Net Cash Remittance ==== |
==== Net Cash Remittance ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=71|p=23}} |
||
====== Net Cash Remittance ====== |
====== Net Cash Remittance ====== |
||
| Line 1,070: | Line 1,081: | ||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col- |
! class="col-m" style="text-align:right" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2}} |
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2}} |
||
| Line 1,076: | Line 1,087: | ||
| style="text-align:right" | |
| style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Ordinary |
| style="text-align:left" | Ordinary remittance |
||
| style="text-align:right" | 7.1 |
| style="text-align:right" | 7.1 |
||
| style="text-align:right" | 7.5 |
| style="text-align:right" | 7.5 |
||
| Line 1,082: | Line 1,093: | ||
| style="text-align:left" | Total |
| style="text-align:left" | Total |
||
| style="text-align:right" | 7.7 |
| style="text-align:right" | 7.7 |
||
| style="text-align:right" | 7.5 |
| style="text-align:right" | <strong>7.5</strong> |
||
|- |
|- |
||
| style="text-align:left" | Remittance ratio{{fn ref|1}} |
| style="text-align:left" | Remittance ratio{{fn ref|1}} |
||
| Line 1,090: | Line 1,101: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=72|p=23}} |
||
====== Net Cash Remittance ====== |
====== Net Cash Remittance ====== |
||
| Line 1,130: | Line 1,141: | ||
=== Solvency II at 224% === |
=== Solvency II at 224% === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=73|p=24}} |
||
====== Foreseeable dividends and share buyback provision ====== |
====== Foreseeable dividends and share buyback provision ====== |
||
| Line 1,136: | Line 1,147: | ||
* Provision for annual [[Definition:Share buyback|share buyback]] for [[Definition:Year 2026|2026]]: EUR -1.25bn |
* Provision for annual [[Definition:Share buyback|share buyback]] for [[Definition:Year 2026|2026]]: EUR -1.25bn |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=74|p=24}} |
||
====== Eligible Own Funds (EOF) ====== |
====== Eligible Own Funds (EOF) / Solvency Capital Requirement (SCR) / Solvency II ratio bridge FY24–FY25 ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id="t24" class="wikitable" |
{| id="t24" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | FY24 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Regulatory & model changes |
||
! style="text-align:right" | |
! class="col-s" style="text-align:right" | Normalized capital generation |
||
! style="text-align:right" | |
! class="col-s" style="text-align:right" | Operating variance |
||
! class="col-s" style="text-align:right" | Economic variance & FX |
|||
! style="text-align:left" | Dividend & annual share buyback |
! style="text-align:left" | Dividend & annual share buyback |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Management actions, debt & other |
||
! style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
| |
|- |
||
| style="text-align:left" | Eligible Own Funds (EOF) |
|||
</div> |
|||
| style="text-align:right" | 55.9 |
|||
| style="text-align:right" | +0.2 |
|||
{{chunk|doc=snjra2xp9r|c=72|p=24}} |
|||
| style="text-align:right" | +8.8 |
|||
====== Solvency II ratio movements ====== |
|||
| style="text-align:right" | -0.4 |
|||
| style="text-align:right" | -2.1 |
|||
* Solvency II ratio: 55.9 (reported) |
|||
| style="text-align:left" | -6.0 / -0.1 |
|||
* Solvency II ratio movements: +0.2 from operating return; +8.8 from market impacts; -0.4 from [[Definition:Capital management|capital management]]; -2.1 from regulatory changes; -6.0 from other impacts; -0.1 from [[Definition:Foreign exchange|FX]] |
|||
| style="text-align:right" | |
|||
* Solvency II ratio at period end: 56.4 (reported) |
|||
| style="text-align:right" | 56.4 |
|||
{{chunk|doc=snjra2xp9r|c=73|p=24}} |
|||
====== Solvency II ratio ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t25" class="wikitable" |
|||
|- |
|- |
||
| style="text-align:left" | Solvency II ratio |
|||
| style="text-align:right" | 216% |
|||
| style="text-align:right" | +0pt |
|||
| style="text-align:right" | +28pts |
|||
| style="text-align:right" | -1pt |
|||
| style="text-align:right" | +4pts |
|||
| style="text-align:left" | -24pts |
|||
| style="text-align:right" | +2pts |
|||
| style="text-align:right" | 224% |
|||
|- |
|||
| style="text-align:left" | Solvency Capital Requirement (SCR) |
|||
| style="text-align:right" | 25.9 |
|||
| style="text-align:right" | 0.0 |
|||
| style="text-align:right" | +0.6 |
|||
| style="text-align:right" | 0.0 |
|||
| style="text-align:right" | -1.2 |
|||
| style="text-align:left" | 0.0 |
|||
| style="text-align:right" | -0.2 |
|||
| style="text-align:right" | 25.2 |
|||
|} |
|} |
||
</div> |
</div> |
||
==== Key sensitivities ==== |
|||
{{chunk|doc=snjra2xp9r|c=74|p=24}} |
|||
====== Solvency II ratio evolution ====== |
|||
* Solvency II ratio was 216%. |
|||
* The ratio increased by +28pts due to operating return. |
|||
* The ratio decreased by -1pt due to market impacts. |
|||
* The ratio increased by +4pts due to [[Definition:Capital management|capital management]]. |
|||
* The ratio decreased by -24pts due to regulatory changes. |
|||
* The ratio increased by +2pts due to other effects. |
|||
* The final Solvency II ratio was 224%. |
|||
{{chunk|doc=snjra2xp9r|c=75|p=24}} |
{{chunk|doc=snjra2xp9r|c=75|p=24}} |
||
====== Solvency |
====== Solvency II ratio ====== |
||
* Solvency II ratio as of December 31, 2025: 224% |
|||
<div style="overflow-x:auto"> |
|||
{| id="t26" class="wikitable" |
|||
|- |
|||
! style="text-align:left" | FY24 |
|||
! style="text-align:left" | Regulatory & model changes |
|||
! style="text-align:left" | Normalized capital generation |
|||
! style="text-align:right" | Operating variance |
|||
! style="text-align:right" | Economic variance & FX |
|||
! style="text-align:left" | Dividend & annual share buyback |
|||
! style="text-align:left" | Management actions, debt & other |
|||
! style="text-align:right" | FY25 |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=76|p=24}} |
{{chunk|doc=snjra2xp9r|c=76|p=24}} |
||
====== |
====== Impact by sensitivity ====== |
||
* Solvency II ratio bridge: 25.9 (start); 0.0 (operating capital generation); +0.6 (market impacts); 0.0 (non-operating items); -1.2 ( |
|||
==== Key sensitivities ==== |
|||
{{chunk|doc=snjra2xp9r|c=77|p=24}} |
|||
====== Impact by scenario ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t25" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Sensitivity |
||
! class="col-s" style="text-align:right" | Impact |
! class="col-s" style="text-align:right" | Impact |
||
|- |
|||
| style="text-align:left" | Ratio as of December 31, 2025 |
|||
| style="text-align:right" | 224% |
|||
|- |
|- |
||
| style="text-align:left" | Interest rate +50bps |
| style="text-align:left" | Interest rate +50bps |
||
| Line 1,234: | Line 1,221: | ||
|- |
|- |
||
| style="text-align:left" | Euro Sovereign spreads +50bps{{fn ref|1}} |
| style="text-align:left" | Euro Sovereign spreads +50bps{{fn ref|1}} |
||
| style="text-align:right" | - |
| style="text-align:right" | -7 pts |
||
|- |
|- |
||
| style="text-align:left" | Credit migration{{fn ref|2}} |
| style="text-align:left" | Credit migration{{fn ref|2}} |
||
| style="text-align:right" | |
| style="text-align:right" | -4 pts |
||
|- |
|- |
||
| style="text-align:left" | Listed Equity (excl. PE & Infra) +25% |
| style="text-align:left" | Listed Equity (excl. PE & Infra) +25% |
||
| style="text-align:right" | - |
| style="text-align:right" | -1 pt |
||
|- |
|- |
||
| style="text-align:left" | Listed Equity (excl. PE & Infra) -25% |
| style="text-align:left" | Listed Equity (excl. PE & Infra) -25% |
||
| style="text-align:right" | |
| style="text-align:right" | +2 pts |
||
|- |
|- |
||
| style="text-align:left" | PE & Infra +25% |
| style="text-align:left" | PE & Infra +25% |
||
| Line 1,261: | Line 1,248: | ||
=== Solvency II – impact of the end of grandfathering period and Solvency II revision === |
=== Solvency II – impact of the end of grandfathering period and Solvency II revision === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=77|p=25}} |
||
====== Solvency II Ratio and Capital Impacts ====== |
|||
====== Ratio as of 31/12/2025 by impact of the end of grandfathering period and Solvency II revision ====== |
|||
* Solvency II Ratio as of 31/12/2025: 224% |
|||
<div style="overflow-x:auto"> |
|||
* Impact of the end of the grandfathering period on January 1, [[Definition:Year 2026|2026]]: -10pts, reducing the ratio to 215% |
|||
{| id="t28" class="wikitable" |
|||
* EUR 2.4bn of grandfathered debt will no longer be eligible as capital from January 1, 2026 |
|||
|- |
|||
* Impact of Solvency II revision, expected to come into effect in 1Q27: +17pts |
|||
| style="text-align:left" | Ratio as of 31/12/2025 |
|||
* No change expected in organic capital generation |
|||
| style="text-align:right" | 224% |
|||
* Additional capital flexibility |
|||
| style="text-align:left" | |
|||
|- |
|||
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026 |
|||
| style="text-align:right" | -10pts to 215% |
|||
| style="text-align:left" | Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026 |
|||
|- |
|||
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27 |
|||
| style="text-align:right" | +17pts{{fn ref|1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}} |
|||
| style="text-align:left" | |
|||
|} |
|||
</div> |
|||
No change expected in organic capital generation<br/> |
|||
Additional capital flexibility |
|||
</td> |
|||
</tr> |
|||
</table> |
|||
{{fn note|1=1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}} |
|||
== Conclusion == |
== Conclusion == |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=78|p=26}} |
||
====== Group CEO ====== |
====== Group CEO ====== |
||
| Line 1,296: | Line 1,267: | ||
=== Conclusion === |
=== Conclusion === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=79|p=27}} |
||
====== Business performance and outlook ====== |
====== Business performance and outlook ====== |
||
* Record results were achieved at the top end of the [[Definition:Target range|target range]] while enhancing reserve prudence. |
* Record results were achieved, at the top end of the [[Definition:Target range|target range]], while enhancing reserve prudence. |
||
* All businesses are |
* All businesses are |
||
* The diversified franchise is well-positioned to capture future growth opportunities. |
|||
* Foundations are being laid for the next plan, with confidence in delivering sustainable earnings growth. |
|||
== Q&A == |
=== Q&A === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=80|p=28}} |
||
====== Date ====== |
====== Date ====== |
||
| Line 1,315: | Line 1,284: | ||
==== Meet our management ==== |
==== Meet our management ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=81|p=29}} |
||
====== Investor |
====== Investor calendar ====== |
||
* March: Roadshows in Europe and US |
* March: Roadshows in Europe and US |
||
| Line 1,327: | Line 1,296: | ||
==== Contact us ==== |
==== Contact us ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=82|p=29}} |
||
====== Investor Relations contact ====== |
====== Investor Relations contact ====== |
||
* Investor Relations contact: +33 1 40 75 48 42 |
* Investor Relations contact number: +33 1 40 75 48 42. |
||
* Investor Relations email: investor.relations@axa.com |
* Investor Relations email: investor.relations@axa.com. |
||
==== Follow us ==== |
==== Follow us ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=83|p=29}} |
||
====== |
====== Website information ====== |
||
* AXA website |
* AXA's website is www.axa.com. |
||
== Appendices == |
== Appendices == |
||
=== Contents === |
|||
{{chunk|doc=snjra2xp9r|c=85|p=31}} |
|||
====== Appendices overview ====== |
|||
{{chunk|doc=snjra2xp9r|c=84|p=31}} |
|||
* The document includes appendices on: Debt and Invested Assets; Additional P&C disclosures; Additional IFRS17 disclosures. |
|||
====== Additional disclosures ====== |
|||
* Debt and Invested Assets are on p.31. |
|||
* Additional P&C disclosures are on p.36. |
|||
* Additional IFRS17 disclosures are on p.41. |
|||
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=85|p=32}} |
||
====== Gross financial debt and maturity breakdown ====== |
====== Gross financial debt and maturity breakdown as of December 31st, 2025 ====== |
||
=== Theme: Gross financial debt and === |
|||
* All figures are in EUR billion. |
|||
==== Gross financial debt ==== |
==== Gross financial debt Contractual maturity breakdown ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=86|p=32}} |
||
====== Debt gearing ====== |
====== Debt gearing ====== |
||
* Debt gearing |
* Debt gearing was 20.6% (prior: 22.3%). |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=87|p=32}} |
||
====== Gross financial debt |
====== Gross financial debt by tier ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t26" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col- |
! class="col-m" style="text-align:right" | FY24 |
||
! class="col- |
! class="col-m" style="text-align:right" | FY25 |
||
! class="col- |
! class="col-m" style="text-align:right" | Jan 1st 2026 |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 19.2 |
|||
| style="text-align:right" | 20.3 |
|||
| style="text-align:right" | 20.3 |
|||
|- |
|- |
||
| style="text-align:left" | Tier 1 |
| style="text-align:left" | Tier 1 |
||
| Line 1,391: | Line 1,359: | ||
| style="text-align:right" | 3.5 |
| style="text-align:right" | 3.5 |
||
| style="text-align:right" | 5.8 |
| style="text-align:right" | 5.8 |
||
|- |
|||
| style="text-align:left" | <strong>Total</strong> |
|||
| style="text-align:right" | <strong>19.2</strong> |
|||
| style="text-align:right" | <strong>20.3</strong> |
|||
| style="text-align:right" | <strong>20.3</strong> |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=88|p=32}} |
||
====== |
====== Debt maturity and types ====== |
||
* |
* The grandfathering period ends on January 1, [[Definition:Year 2026|2026]]. |
||
* EUR 0.4bn redeemed in |
* EUR 0.4bn will be redeemed in January 2026. |
||
* Debt types include Tier 1, Tier 2, and Senior debt. |
|||
{{chunk|doc=snjra2xp9r|c=89|p=32}} |
|||
==== Contractual maturity breakdown ==== |
|||
====== Senior debt, Tier 2, Tier 1 by contractual maturity ====== |
|||
{{chunk|doc=snjra2xp9r|c=90|p=32}} |
|||
====== Contractual maturity breakdown (In Euro billion) ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t27" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,425: | Line 1,397: | ||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 1.5 |
| style="text-align:right" | 1.5 |
||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| Line 1,435: | Line 1,407: | ||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | 10.8 |
| style="text-align:right" | 10.8 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.6 |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
|- |
|- |
||
| Line 1,449: | Line 1,421: | ||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
|} |
|} |
||
</div> |
</div> |
||
==== o/w Grandfathered debt (Contractual maturity breakdown) ==== |
|||
{{chunk|doc=snjra2xp9r|c=91|p=32}} |
|||
====== Contractual maturity breakdown ====== |
|||
{{chunk|doc=snjra2xp9r|c=90|p=32}} |
|||
* Grandfathered debt is included in the contractual maturity breakdown. |
|||
====== o/w Grandfathered debt (Contractual maturity breakdown) ====== |
|||
{{chunk|doc=snjra2xp9r|c=92|p=32}} |
|||
====== Tier 1 & Tier 2 by 2025, 2026, 2027, 2028, 2029, 2030, 2031-2039, ≥2040, Undated ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t28" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,502: | Line 1,471: | ||
==== Economic maturity breakdown ==== |
==== Economic maturity breakdown ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=91|p=32}} |
||
====== Economic maturity breakdown |
====== Economic maturity breakdown (In Euro billion) ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t29" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,534: | Line 1,503: | ||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 2.4 |
| style="text-align:right" | 2.4 |
||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| style="text-align:right" | 2.0 |
| style="text-align:right" | 2.0 |
||
| style="text-align:right" | 0.4 |
|||
| style="text-align:right" | 6.4 |
| style="text-align:right" | 6.4 |
||
| style="text-align:right" | |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Tier 1 |
| style="text-align:left" | Tier 1 |
||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | |
|||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | 0.4 |
|||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | 4.0 |
| style="text-align:right" | 4.0 |
||
| style="text-align:right" | |
|||
|} |
|} |
||
</div> |
</div> |
||
==== o/w Grandfathered debt (Economic maturity breakdown) ==== |
|||
{{chunk|doc=snjra2xp9r|c=94|p=32}} |
|||
====== Grandfathered debt ====== |
|||
{{chunk|doc=snjra2xp9r|c=92|p=32}} |
|||
* o/w Grandfathered debt |
|||
====== Grandfathered debt by economic maturity and tier ====== |
|||
{{chunk|doc=snjra2xp9r|c=95|p=32}} |
|||
====== Tier 1 & Tier 2 by economic maturity ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t30" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,605: | Line 1,571: | ||
=== General Account Invested Assets === |
=== General Account Invested Assets === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=93|p=33}} |
||
====== General Account invested assets |
====== General Account invested assets ====== |
||
* [[Definition:Full year 2025|FY25]] Total General Account invested assets |
* [[Definition:Full year 2025|FY25]] Total General Account invested assets |
||
* Duration gap at -0.4 year |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=94|p=33}} |
||
====== FY25 Total General Account invested assets: Euro 450 billion ====== |
====== FY25 Total General Account invested assets: Euro 450 billion ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t31" class="wikitable fintable" |
||
|- |
|- |
||
| style="text-align:left" | Fixed income |
| style="text-align:left" | Fixed income |
||
| style="text-align:right" | 77% |
|||
|- |
|- |
||
| style="text-align:left" | Real estate |
| style="text-align:left" | Real estate |
||
| style="text-align:right" | 9% |
|||
|- |
|- |
||
| style="text-align:left" | Infrastructure equity |
| style="text-align:left" | Infrastructure equity |
||
| style="text-align:right" | 2% |
|||
|- |
|- |
||
| style="text-align:left" | Listed equities |
| style="text-align:left" | Listed equities |
||
| style="text-align:right" | 2% |
|||
|- |
|- |
||
| style="text-align:left" | Private equity and hedge funds |
| style="text-align:left" | Private equity and hedge funds |
||
| style="text-align:right" | 5% |
|||
|- |
|- |
||
| style="text-align:left" | Cash |
| style="text-align:left" | Cash |
||
| style="text-align:right" | 4% |
|||
|- |
|- |
||
| style="text-align:left" | Policy loans |
| style="text-align:left" | Policy loans |
||
| style="text-align:right" | 0% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=95|p=33}} |
||
====== Invested assets (100%) In Euro billion ====== |
====== Invested assets (100%) In Euro billion ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t32" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,688: | Line 1,662: | ||
</div> |
</div> |
||
{{fn note|1=1|2=Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial & |
{{fn note|1=1|2=Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial & Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).}} |
||
{{fn note|1=2|2=Includes hedges. Listed equities excluding hedges at Euro 14 billion.}} |
{{fn note|1=2|2=Includes hedges. Listed equities excluding hedges at Euro 14 billion.}} |
||
{{fn note|1=3|2=Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}} |
{{fn note|1=3|2=Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}} |
||
| Line 1,695: | Line 1,669: | ||
=== Structured and Private Credit assets === |
=== Structured and Private Credit assets === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=96|p=34}} |
||
====== |
====== Structured and Private Credit assets ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t33" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | Invested assets (100%)<br/>In Euro billion |
! style="text-align:left" | Invested assets (100%)<br/>In Euro billion |
||
! style="text-align:right" | FY25 |
! class="col-m" style="text-align:right" | FY25 |
||
! style="text-align:right" | % of total G/A{{fn ref|1}} portfolio |
! class="col-m" style="text-align:right" | % of total G/A{{fn ref|1}} portfolio |
||
! style="text-align: |
! style="text-align:left" | Comments |
||
|- |
|||
| style="text-align:left" | Residential Mortgages |
|||
| style="text-align:right" | 16 |
|||
| style="text-align:right" | 4% |
|||
| style="text-align:left" | - €6bn Dutch mortgages, NHG guaranteed<br/>- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
|||
|- |
|||
| style="text-align:left" | CLO & ABS |
|||
| style="text-align:right" | 25 |
|||
| style="text-align:right" | 6% |
|||
| style="text-align:left" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
|||
|- |
|||
| style="text-align:left" | Infrastructure debt |
|||
| style="text-align:right" | 8 |
|||
| style="text-align:right" | 2% |
|||
| style="text-align:left" | - Skewed towards resilient industries (Telecom, Utilities, Transport) |
|||
|- |
|||
| style="text-align:left" | CRE debt |
|||
| style="text-align:right" | 8 |
|||
| style="text-align:right" | 2% |
|||
| style="text-align:left" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
|||
|- |
|||
| style="text-align:left" | Mid-Market lending |
|||
| style="text-align:right" | 10 |
|||
| style="text-align:right" | 2% |
|||
| style="text-align:left" | - Strong diversification with €8m average ticket<br/>- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation |
|||
|- |
|||
| style="text-align:left" | Other |
|||
| style="text-align:right" | 2 |
|||
| style="text-align:right" | 0% |
|||
| style="text-align:left" | |
|||
|- |
|||
| style="text-align:left" | <strong>Total Structured and Private Credit Assets</strong> |
|||
| style="text-align:right" | <strong>69</strong> |
|||
| style="text-align:right" | <strong>15%</strong> |
|||
| style="text-align:left" | o/w 54% participating |
|||
|} |
|} |
||
</div> |
</div> |
||
<tr><td>Residential Mortgages</td><td>16</td><td>4%</td><td>- €6bn Dutch mortgages, NHG guaranteed<br>- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)</td></tr> |
|||
<tr><td>CLO & ABS</td><td>25</td><td>6%</td><td>- 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)</td></tr> |
|||
<tr><td>Infrastructure debt</td><td>8</td><td>2%</td><td>- Skewed towards resilient industries (Telecom, Utilities, Transport)</td></tr> |
|||
<tr><td>CRE debt</td><td>8</td><td>2%</td><td>- Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV</td></tr> |
|||
<tr><td>Mid-Market lending</td><td>10</td><td>2%</td><td>- Strong diversification with €8m average ticket<br>- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation</td></tr> |
|||
<tr><td>Other</td><td>2</td><td>0%</td><td></td></tr> |
|||
<tr><td><strong>Total Structured and Private Credit Assets</strong></td><td><strong>69</strong></td><td><strong>15%</strong></td><td>o/w 54% participating</td></tr> |
|||
</table> |
|||
{{fn note|1=1|2=G/A: General Account}} |
{{fn note|1=1|2=G/A: General Account}} |
||
| Line 1,722: | Line 1,723: | ||
==== FY25 Fixed Income Reinvestment ==== |
==== FY25 Fixed Income Reinvestment ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=97|p=35}} |
||
====== |
====== FY25 fixed income reinvestment allocation ====== |
||
* EUR 57bn in fixed income reinvestment |
|||
* Government bonds & related comprise 32% of the portfolio with an average rating of AA. |
|||
* |
* Government bonds & related: 32% of reinvestment, average rating AA |
||
* Investment grade credit: 40% of reinvestment, average rating A |
|||
* ABS/CLO/IG fund financing comprises 21% of the portfolio. |
|||
* ABS/CLO/IG fund financing: 21% of reinvestment |
|||
* Below investment grade credit comprises 7% of the portfolio. |
|||
* Below investment grade credit: 7% of reinvestment |
|||
* The total reinvestment amount is EUR 57bn. |
|||
==== FY25 Fixed Income Reinvestment Yield ==== |
==== FY25 Fixed Income Reinvestment Yield ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=98|p=35}} |
||
====== Fixed |
====== FY25 Fixed Income Reinvestment Yield ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t34" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | Public fixed income{{fn ref|1}} |
! style="text-align:left" | Public fixed income{{fn ref|1}} |
||
| Line 1,749: | Line 1,750: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=99|p=35}} |
||
====== |
====== Fixed income investment details ====== |
||
* EUR 57bn fixed income invested at 3.9% |
* EUR 57bn fixed income invested at 3.9% |
||
| Line 1,757: | Line 1,758: | ||
* Gradual shift from alternative total return assets to Private & Structured credit |
* Gradual shift from alternative total return assets to Private & Structured credit |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=100|p=35}} |
||
====== FY25 Fixed Income Reinvestment Yield ====== |
====== FY25 Fixed Income Reinvestment Yield ====== |
||
| Line 1,763: | Line 1,764: | ||
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}} |
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}} |
||
=== Contents === |
|||
{{chunk|doc=snjra2xp9r|c=104|p=36}} |
|||
{{chunk|doc=snjra2xp9r|c=101|p=36}} |
|||
====== Additional disclosures ====== |
====== Additional disclosures ====== |
||
* |
* Debt and Invested Assets are detailed on p.31. |
||
* Additional |
* Additional P&C disclosures are provided on p.36. |
||
* |
* Additional IFRS17 disclosures are available on p.41. |
||
=== AXA XL Insurance – Large Commercial & Specialty business === |
=== AXA XL Insurance – Large Commercial & Specialty business === |
||
| Line 1,774: | Line 1,777: | ||
==== Well diversified across lines of business and geographies ==== |
==== Well diversified across lines of business and geographies ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=102|p=37}} |
||
====== GWP by line of business ====== |
====== FY25 GWP by line of business ====== |
||
* [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|GWP]] by line of business: USD 19bn |
|||
<div style="overflow-x:auto"> |
|||
** Casualty: 35% |
|||
{| id="t38" class="wikitable fintable" |
|||
** Property: 29% |
|||
|- |
|||
** Specialty: 19% |
|||
| style="text-align:left" | Casualty |
|||
** Professional lines: 17% |
|||
| style="text-align:right" | 35% |
|||
|- |
|||
| style="text-align:left" | Property |
|||
| style="text-align:right" | 29% |
|||
|- |
|||
| style="text-align:left" | Specialty |
|||
| style="text-align:right" | 19% |
|||
|- |
|||
| style="text-align:left" | Professional lines{{fn ref|1}} |
|||
| style="text-align:right" | 17% |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=103|p=37}} |
||
====== GWP by geography ====== |
====== FY25 GWP by geography ====== |
||
* [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|GWP]] by geography: USD 19bn |
|||
<div style="overflow-x:auto"> |
|||
** Americas: 46% |
|||
{| id="t39" class="wikitable fintable" |
|||
** Europe & APAC: 35% |
|||
|- |
|||
** UK & Lloyds: 19% |
|||
| style="text-align:left" | Americas |
|||
| style="text-align:right" | 46% |
|||
|- |
|||
| style="text-align:left" | Europe & APAC |
|||
| style="text-align:right" | 35% |
|||
|- |
|||
| style="text-align:left" | UK & Lloyds |
|||
| style="text-align:right" | 19% |
|||
|} |
|||
</div> |
|||
==== Leading market positions across lines ==== |
==== Leading market positions across lines ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=104|p=37}} |
||
====== |
====== Leading market positions ====== |
||
* Top 3 globally |
* Top 3 globally |
||
* Multinational Programs |
|||
* Marine |
|||
* Fine Art & Specie |
|||
==== Managing the cycle to deliver consistent profitability ==== |
==== Managing the cycle to deliver consistent profitability ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=105|p=37}} |
||
====== |
====== Commercial lines performance by segment ====== |
||
* Bubble chart axes: Ex-price growth (%) (x-axis) and Profitability (y-axis). |
|||
* Segments shown in the bubble chart: |
|||
** Property: high profitability, high ex-price growth |
|||
** Specialty |
|||
** Casualty |
|||
** Professional lines: lower profitability, lower ex-price growth |
|||
{{chunk|doc=snjra2xp9r|c=106|p=37}} |
|||
====== Managing the cycle to deliver consistent profitability ====== |
|||
{{fn note|1=1|2=Including Cyber}} |
|||
* Profitability vs. Ex-price growth (%) |
|||
{{fn note|1=2|2=Source: McKinsey}} |
|||
** Professional lines: lower ex-price growth, lower profitability |
|||
{{fn note|1=3|2=Source: Aon, Guy Carpenter, and Global Market Insights}} |
|||
** Casualty: medium ex-price growth, medium profitability |
|||
{{fn note|1=4|2=Source: Industry Research Biz (January 2026)}} |
|||
** Specialty (including Cyber): medium-high ex-price growth, medium-high profitability |
|||
** Property: high ex-price growth, high profitability |
|||
=== P&C – Focus on Reserves === |
=== P&C – Focus on Reserves === |
||
| Line 1,833: | Line 1,828: | ||
==== Claims reserves ratio ==== |
==== Claims reserves ratio ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=107|p=38}} |
||
====== Claims reserves ratio definition ====== |
====== Claims reserves ratio definition ====== |
||
* Net undiscounted claims reserves |
* Claims reserves ratio is defined as Net undiscounted claims reserves divided by Net earned premiums. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=108|p=38}} |
||
====== Claims reserves ratio |
====== Claims reserves ratio ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t35" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,849: | Line 1,844: | ||
! class="col-s" style="text-align:right" | FY20 |
! class="col-s" style="text-align:right" | FY20 |
||
! class="col-s" style="text-align:right" | FY21 |
! class="col-s" style="text-align:right" | FY21 |
||
! class="col-s" style="text-align:right" | FY22 |
! class="col-s" style="text-align:right" | FY22 (IFRS4) |
||
! class="col-s" style="text-align:right" | FY22 |
! class="col-s" style="text-align:right" | FY22 (IFRS17) |
||
! class="col-s" style="text-align:right" | FY23 |
! class="col-s" style="text-align:right" | FY23 |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|||
! style="text-align:left" | |
|||
! colspan="5" style="text-align:center" | IFRS4 |
|||
! colspan="4" style="text-align:center" | IFRS17 |
|||
|- |
|- |
||
| style="text-align:left" | Claims reserves ratio |
| style="text-align:left" | Claims reserves ratio |
||
| Line 1,874: | Line 1,865: | ||
==== Technical reserves ratio ==== |
==== Technical reserves ratio ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=109|p=38}} |
||
====== |
====== Net undiscounted technical reserves ratio ====== |
||
* The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums. |
* The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=110|p=38}} |
||
====== Technical reserves ratio |
====== Technical reserves ratio ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t36" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,890: | Line 1,881: | ||
! class="col-s" style="text-align:right" | FY20 |
! class="col-s" style="text-align:right" | FY20 |
||
! class="col-s" style="text-align:right" | FY21 |
! class="col-s" style="text-align:right" | FY21 |
||
! class="col-s" style="text-align:right" | FY22 |
! class="col-s" style="text-align:right" | FY22 (IFRS4) |
||
! class="col-s" style="text-align:right" | FY22 |
! class="col-s" style="text-align:right" | FY22 (IFRS17) |
||
! class="col-s" style="text-align:right" | FY23 |
! class="col-s" style="text-align:right" | FY23 |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|||
! style="text-align:left" | |
|||
! colspan="5" style="text-align:center" | IFRS4 |
|||
! colspan="4" style="text-align:center" | IFRS17 |
|||
|- |
|- |
||
| style="text-align:left" | Technical reserves ratio |
| style="text-align:left" | Technical reserves ratio |
||
| Line 1,917: | Line 1,904: | ||
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program === |
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=111|p=39}} |
||
====== |
====== Currency basis ====== |
||
* All figures are in |
* All figures are in Euro. |
||
{{chunk|doc=snjra2xp9r|c=112|p=39}} |
|||
==== Insurance segment (occurrence protection) ==== |
|||
====== Capacity & Retention by peril ====== |
|||
==== Reinsurance segment (illustrative) ==== |
|||
{{chunk|doc=snjra2xp9r|c=114|p=39}} |
|||
====== Alternative Capital & Cat Bonds ====== |
|||
* Alternative Capital & Cat Bonds |
|||
{{chunk|doc=snjra2xp9r|c=115|p=39}} |
|||
====== Capacity and Retention by peril ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t37" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,944: | Line 1,922: | ||
! class="col-s" style="text-align:right" | NA Earthquake |
! class="col-s" style="text-align:right" | NA Earthquake |
||
! class="col-s" style="text-align:right" | Per other perils{{fn ref|3}} |
! class="col-s" style="text-align:right" | Per other perils{{fn ref|3}} |
||
! style="text-align:left" | Reinsurance segment (illustrative) — Alternative Capital & Cat Bonds |
|||
|- |
|- |
||
| style="text-align:left" | Capacity |
| style="text-align:left" | Capacity |
||
| Line 1,952: | Line 1,931: | ||
| style="text-align:right" | 1.2bn |
| style="text-align:right" | 1.2bn |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:left" | |
|||
|- |
|- |
||
| style="text-align:left" | Retention |
| style="text-align:left" | Retention |
||
| Line 1,960: | Line 1,940: | ||
| style="text-align:right" | 600m{{fn ref|2}} |
| style="text-align:right" | 600m{{fn ref|2}} |
||
| style="text-align:right" | 400m |
| style="text-align:right" | 400m |
||
| style="text-align:left" | |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=113|p=39}} |
||
====== |
====== 2026 Simplified Group Nat Cat Reinsurance Program ====== |
||
* |
* Retention levels are expected to remain stable in [[Definition:Year 2026|2026]], consistent with 2025 levels. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=114|p=39}} |
||
====== P&C – 2026 Simplified Group Nat Cat Reinsurance Program ====== |
|||
====== Reinsurance segment (illustrative) ====== |
|||
{{fn note|1=1|2=Excludes local reinsurance covers;}} |
{{fn note|1=1|2=Excludes local reinsurance covers;}} |
||
| Line 1,977: | Line 1,958: | ||
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026 === |
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026 === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=115|p=40}} |
||
====== Nat Cat cost deviation ====== |
====== Nat Cat cost deviation ====== |
||
* Nat Cat cost deviation |
* Nat Cat cost deviation is presented in EUR billion, net of reinsurance. |
||
==== Group underlying earnings deviation to average Nat Cat charges in 2026 ==== |
==== Group underlying earnings deviation to average Nat Cat charges in 2026 ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=116|p=40}} |
||
====== |
====== Net of reinsurance ====== |
||
* The |
* The data is presented both net of reinsurance, post-tax, and net of reinsurance, pre-tax. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=117|p=40}} |
||
====== Deviation by |
====== Deviation by scenario and percentile ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t38" class="wikitable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Scenario |
||
! style="text-align:right" | |
! style="text-align:right" | Percentile |
||
! style="text-align:right" | Deviation |
! style="text-align:right" | Deviation |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1/20y more severe |
||
| style="text-align:right" | |
| style="text-align:right" | 95th |
||
| style="text-align:right" | €-1.2bn |
| style="text-align:right" | €-1.2bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1/10y more severe |
||
| style="text-align:right" | |
| style="text-align:right" | 90th |
||
| style="text-align:right" | €-0.8bn |
| style="text-align:right" | €-0.8bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1/5y more severe |
||
| style="text-align:right" | |
| style="text-align:right" | 80th |
||
| style="text-align:right" | €-0.4bn |
| style="text-align:right" | €-0.4bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Median |
||
| style="text-align:right" | |
| style="text-align:right" | 50th |
||
| style="text-align:right" | €+0.1bn |
| style="text-align:right" | €+0.1bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1/5y less severe |
||
| style="text-align:right" | |
| style="text-align:right" | 20th |
||
| style="text-align:right" | €+0.5bn |
| style="text-align:right" | €+0.5bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1/10y less severe |
||
| style="text-align:right" | |
| style="text-align:right" | 10th |
||
| style="text-align:right" | €+0.7bn |
| style="text-align:right" | €+0.7bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1/20y less severe |
||
| style="text-align:right" | |
| style="text-align:right" | 5th |
||
| style="text-align:right" | €+0.8bn |
| style="text-align:right" | €+0.8bn |
||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=118|p=40}} |
||
====== Nat Cat charges deviation ====== |
====== Nat Cat charges deviation ====== |
||
| Line 2,037: | Line 2,018: | ||
==== Average Expected Nat Cat charges ==== |
==== Average Expected Nat Cat charges ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=119|p=40}} |
||
====== |
====== Amount & Estimated impact on GEP by year ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t39" class="wikitable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 2,047: | Line 2,028: | ||
! style="text-align:right" | 2026 |
! style="text-align:right" | 2026 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Amount (€bn) |
||
| style="text-align:right" | 2.6 |
| style="text-align:right" | 2.6 |
||
| style="text-align:right" | 2.7 |
| style="text-align:right" | 2.7 |
||
| Line 2,059: | Line 2,040: | ||
{{fn note|1=1|2=Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). Full Year 2025 Earnings}} |
{{fn note|1=1|2=Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). Full Year 2025 Earnings}} |
||
=== Contents === |
|||
{{chunk|doc=snjra2xp9r|c=123|p=41}} |
|||
{{chunk|doc=snjra2xp9r|c=120|p=41}} |
|||
====== Additional disclosures ====== |
====== Additional disclosures ====== |
||
* Debt and Invested Assets |
* Additional disclosures include Debt and Invested Assets on p.31. |
||
* Additional P&C disclosures are on p.36 |
* Additional P&C disclosures are on p.36. |
||
* Additional IFRS17 disclosures are on p.41 |
* Additional IFRS17 disclosures are on p.41. |
||
=== P&C – Margin Analysis === |
=== P&C – Margin Analysis === |
||
| Line 2,070: | Line 2,053: | ||
==== Technical Result ==== |
==== Technical Result ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=121|p=42}} |
||
====== Pre-tax technical result ====== |
====== Pre-tax technical result ====== |
||
* |
* Pre-tax technical result in EUR million. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=122|p=42}} |
||
====== Current Accident Year Undiscounted Technical Margin ====== |
====== Current Accident Year Undiscounted Technical Margin by FY25 ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t40" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col- |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col- |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | <strong>Current Accident Year Undiscounted Technical Margin</strong> |
| style="text-align:left" | <strong>Current Accident Year Undiscounted Technical Margin</strong> |
||
| style="text-align:right" | 2,778 |
| style="text-align:right" | 2,778 |
||
| style="text-align:right" | +707 |
| style="text-align:right" | +707 |
||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=123|p=42}} |
|||
====== Gross Earned Premiums and Current Accident Year Undiscounted Combined Ratio ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t41" class="wikitable fintable" |
|||
|- |
|- |
||
| style="text-align:left" | Gross Earned Premiums |
| style="text-align:left" | Gross Earned Premiums |
||
| Line 2,097: | Line 2,088: | ||
| style="text-align:right" | -1.0pt |
| style="text-align:right" | -1.0pt |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | o/w Nat Cats |
||
| style="text-align:right" | |
| style="text-align:right" | 3.4% |
||
| style="text-align:right" | |
| style="text-align:right" | -0.4pt |
||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=124|p=42}} |
||
====== Current Accident Year Discounting |
====== Current Accident Year Discounting ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t42" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 2,135: | Line 2,126: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=125|p=42}} |
||
====== Prior Years' Reserve Development (PYD) ====== |
====== Prior Years' Reserve Development (PYD) ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t43" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 2,155: | Line 2,146: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=126|p=42}} |
||
====== FY25 Current Accident Year discount rate |
====== FY25 sensitivity to Current Accident Year discount rate changes ====== |
||
<div style="overflow-x:auto"> |
|||
* [[Definition:Full year 2025|FY25]] sensitivity to Current Accident Year discount rate changes: +25bps results in EUR +0.2bn; -25bps results in EUR -0.2bn. |
|||
{| id="t44" class="wikitable" |
|||
|- |
|||
! style="text-align:left" | +25bps |
|||
! style="text-align:right" | -25bps |
|||
|- |
|||
| style="text-align:left" | €+0.2bn |
|||
| style="text-align:right" | €-0.2bn |
|||
|} |
|||
</div> |
|||
==== Financial Result ==== |
==== Financial Result ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=127|p=42}} |
||
====== Pre-tax results ====== |
====== Pre-tax results ====== |
||
* All figures are in EUR million (pre-tax). |
* All figures are in EUR million (pre-tax). |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=128|p=42}} |
||
====== Investment |
====== Investment Income ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t45" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 2,195: | Line 2,195: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=129|p=42}} |
||
====== Insurance |
====== Insurance finance expenses ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t46" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 2,219: | Line 2,219: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=130|p=42}} |
||
====== Insurance |
====== 2026e Insurance Finance Expenses (pre-tax) by change in 2025 current AY Discount ====== |
||
<div style="overflow-x:auto"> |
|||
* 2026e Insurance Finance Expenses (pre-tax): ~ EUR -1.4bn |
|||
{| id="t47" class="wikitable" |
|||
* Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount: |
|||
|- |
|||
** +25bps: ~ EUR -50m |
|||
! style="text-align:left" | +25bps |
|||
** -25bps: ~ EUR +50m |
|||
! style="text-align:right" | -25bps |
|||
|- |
|||
| style="text-align:left" | ~ €-50m |
|||
| style="text-align:right" | ~€+50m |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=131|p=42}} |
||
====== Underlying |
====== Underlying earnings before tax, tax, affiliates, minority interests & other, and underlying earnings ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t48" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col- |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | <strong>Underlying Earnings before tax</strong> |
| style="text-align:left" | <strong>Underlying Earnings before tax</strong> |
||
| Line 2,255: | Line 2,261: | ||
| style="text-align:left" | <em>Growth vs. FY24 (at constant FX)</em> |
| style="text-align:left" | <em>Growth vs. FY24 (at constant FX)</em> |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | +9% |
||
|} |
|} |
||
</div> |
</div> |
||
| Line 2,264: | Line 2,270: | ||
=== L&H – Margin Analysis === |
=== L&H – Margin Analysis === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=132|p=43}} |
||
====== Scope impact ====== |
====== Scope impact ====== |
||
* |
* Includes scope impact. |
||
==== Technical Result ==== |
==== Technical Result ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=133|p=43}} |
||
====== Pre-tax technical result ====== |
====== Pre-tax technical result ====== |
||
* Pre-tax technical result in EUR million |
* Pre-tax technical result (in EUR million): |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=134|p=43}} |
||
====== Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio ====== |
====== Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t49" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 2,286: | Line 2,292: | ||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | < |
| style="text-align:left" | <strong>Short-term Technical Margin</strong> |
||
| style="text-align:right" | |
| style="text-align:right" | 479 |
||
| style="text-align:right" | |
| style="text-align:right" | +60 |
||
|- |
|- |
||
| style="text-align:left" | Gross Earned Premiums |
| style="text-align:left" | Gross Earned Premiums |
||
| Line 2,300: | Line 2,306: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=135|p=43}} |
||
====== Laya recapture ====== |
|||
* Includes recapture of Laya. |
|||
{{chunk|doc=snjra2xp9r|c=136|p=43}} |
|||
====== Long-term Technical Margin by CSM release and Technical experience ====== |
====== Long-term Technical Margin by CSM release and Technical experience ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t50" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col- |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col- |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | < |
| style="text-align:left" | <strong>Long-term Technical Margin</strong> |
||
| style="text-align:right" | |
| style="text-align:right" | 2,804 |
||
| style="text-align:right" | |
| style="text-align:right" | +156 |
||
|- |
|- |
||
| style="text-align:left" | CSM release |
| style="text-align:left" | CSM release |
||
| Line 2,324: | Line 2,335: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=137|p=43}} |
||
====== FY25 CSM by interest rates, sovereign spreads, corporate spread, equities ====== |
|||
====== Technical result adjustments ====== |
|||
* The technical result includes the recapture of Laya. |
|||
{{chunk|doc=snjra2xp9r|c=139|p=43}} |
|||
====== FY25 CSM by sensitivities ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t51" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | Baseline |
|||
! class="col-s" style="text-align:right" | 33.3 |
|||
|- |
|||
| style="text-align:left" | Interest rates +50bps |
|||
| style="text-align:right" | -0.8 |
|||
|- |
|||
| style="text-align:left" | Interest rates -50bps |
|||
| style="text-align:right" | 0.6 |
|||
|- |
|||
| style="text-align:left" | Sovereign spreads +50bps |
|||
| style="text-align:right" | -1.9 |
|||
|- |
|||
| style="text-align:left" | Sovereign spreads -50bps |
|||
| style="text-align:right" | 1.9 |
|||
|- |
|||
| style="text-align:left" | Corporate spread +50bps |
|||
| style="text-align:right" | -0.8 |
|||
|- |
|||
| style="text-align:left" | Corporate spread -50bps |
|||
| style="text-align:right" | 0.7 |
|||
|- |
|||
| style="text-align:left" | Equities +25% |
|||
| style="text-align:right" | 1.8 |
|||
|- |
|||
| style="text-align:left" | Equities -25% |
|||
| style="text-align:right" | -2.2 |
|||
|} |
|} |
||
</div> |
</div> |
||
(in Euro billion)</caption> |
|||
<tr><th></th><th>[[Definition:Full year 2025|FY25]]</th></tr> |
|||
<tr><td><b>Baseline</b></td><td>33.3</td></tr> |
|||
<tr><td>Interest rates +50bps</td><td>-0.8</td></tr> |
|||
<tr><td>Interest rates -50bps</td><td>0.6</td></tr> |
|||
<tr><td>Sovereign spreads +50bps</td><td>-1.9</td></tr> |
|||
<tr><td>Sovereign spreads -50bps</td><td>1.9</td></tr> |
|||
<tr><td>Corporate spread +50bps</td><td>-0.8</td></tr> |
|||
<tr><td>Corporate spread -50bps</td><td>0.7</td></tr> |
|||
<tr><td>Equities +25%</td><td>1.8</td></tr> |
|||
<tr><td>Equities -25%</td><td>-2.2</td></tr> |
|||
</table> |
|||
==== Financial Result ==== |
==== Financial Result ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=138|p=43}} |
||
====== Pre-tax result ====== |
====== Pre-tax result by segment ====== |
||
* Pre-tax result |
* Pre-tax result: EUR 7,604m |
||
** France: EUR 2,000m |
|||
** Europe: EUR 2,000m |
|||
** AXA XL: EUR 1,500m |
|||
** Asia: EUR 1,000m |
|||
** International: EUR 500m |
|||
** [[Definition:AXA Investment Managers|AXA IM]]: EUR 200m |
|||
** Other: EUR 400m |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=139|p=43}} |
||
====== Investment |
====== Investment income (non-VFA only) ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t52" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | < |
| style="text-align:left" | <strong>Investment Income (non-VFA only)</strong> |
||
| style="text-align:right" | |
| style="text-align:right" | 2,484 |
||
| style="text-align:right" | |
| style="text-align:right" | -1 |
||
|- |
|- |
||
| style="text-align:left" | FY25 Average Assets |
| style="text-align:left" | FY25 Average Assets |
||
| Line 2,384: | Line 2,412: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=140|p=43}} |
||
====== Insurance Finance Expenses (non-VFA only) ====== |
====== Insurance Finance Expenses (non-VFA only) ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t53" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | < |
| style="text-align:left" | <strong>Insurance Finance Expenses (non-VFA only)</strong> |
||
| style="text-align:right" | |
| style="text-align:right" | -1,538 |
||
| style="text-align:right" | |
| style="text-align:right" | -9 |
||
|- |
|- |
||
| style="text-align:left" | FY24 Reserves at locked-in rate |
| style="text-align:left" | FY24 Reserves at locked-in rate |
||
| Line 2,408: | Line 2,436: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=141|p=43}} |
||
====== Underlying |
====== Underlying Earnings before tax, Tax, Affiliates, Minority interests & Other, Underlying Earnings ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t54" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | < |
| style="text-align:left" | <strong>Underlying Earnings before tax</strong> |
||
| style="text-align:right" | |
| style="text-align:right" | 4,229 |
||
| style="text-align:right" | |
| style="text-align:right" | +205 |
||
|- |
|- |
||
| style="text-align:left" | Tax |
| style="text-align:left" | Tax |
||
| Line 2,430: | Line 2,458: | ||
| style="text-align:right" | -51 |
| style="text-align:right" | -51 |
||
|- |
|- |
||
| style="text-align:left" | < |
| style="text-align:left" | <strong>Underlying Earnings</strong> |
||
| style="text-align:right" | |
| style="text-align:right" | 3,501 |
||
| style="text-align:right" | |
| style="text-align:right" | +219 |
||
|- |
|- |
||
| style="text-align:left" | < |
| style="text-align:left" | <em>Growth vs. FY24 (at constant FX)</em> |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | +7% |
| style="text-align:right" | +7% |
||
| Line 2,442: | Line 2,470: | ||
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}} |
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}} |
||
=== Contents === |
|||
{{chunk|doc=snjra2xp9r|c=144|p=44}} |
|||
{{chunk|doc=snjra2xp9r|c=142|p=44}} |
|||
====== Additional disclosures ====== |
====== Additional disclosures ====== |
||
* Debt and Invested Assets |
* Additional disclosures include Debt and Invested Assets. |
||
* Additional P&C disclosures |
* Additional disclosures include P&C disclosures. |
||
* Additional |
* Additional disclosures include IFRS17 disclosures. |
||
=== Expanding AXA's role in society: AXA for Progress Index === |
=== Expanding AXA's role in society: AXA for Progress Index === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=143|p=45}} |
||
====== |
====== 2025 Result by As a GLOBAL INVESTOR, As a GLOBAL INSURER, As a COMPANY ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t55" class="wikitable" |
||
|- |
|- |
||
! colspan="2" style="text-align:center" | As a GLOBAL INVESTOR |
! colspan="2" style="text-align:center" | As a GLOBAL INVESTOR |
||
| Line 2,501: | Line 2,531: | ||
=== Sustainability Performance & Ratings === |
=== Sustainability Performance & Ratings === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=144|p=46}} |
||
====== Sustainability ratings ====== |
====== Sustainability ratings ====== |
||
* Dow Jones Best-in-Class Europe & World indices |
* S&P Global: 97th percentile in Dow Jones Best-in-Class Europe & World indices for 2025. |
||
* MSCI |
* MSCI: AAA score for 2025. |
||
* CDP |
* CDP: B score for 2025. |
||
* Sustainalytics ESG Risk Rating |
* Morningstar Sustainalytics: ESG Risk Rating of 17.0 (Low risk) for 2025. |
||
* |
* FTSE Russell: 4.3/5 score in FTSE4Good Index Series for 2025. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=145|p=46}} |
||
====== Sustainability Performance & Ratings ====== |
====== Sustainability Performance & Ratings ====== |
||
| Line 2,517: | Line 2,547: | ||
=== Scope === |
=== Scope === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=146|p=47}} |
||
====== Scope of activities by geography and segment ====== |
====== Scope of activities by geography and segment ====== |
||
* France: includes insurance activities, banking activities, and holding. |
* France: includes insurance activities, banking activities, and holding. |
||
* Europe: includes Switzerland (insurance activities) |
* Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxembourg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities). |
||
* AXA XL: includes insurance and reinsurance activities and holding. |
* AXA XL: includes insurance and reinsurance activities and holding. |
||
* Asia, Africa & EME-LATAM: |
* Asia, Africa & EME-LATAM: |
||
** Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated. |
** Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated. |
||
** Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 |
** Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, [[Definition:Underlying earnings|underlying earnings]], and net income. |
||
** Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), |
** Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), Egypt (insurance activities and holding) are fully consolidated. |
||
** EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated. |
** EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated. |
||
** EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income. |
** EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income. |
||
** |
** AXA Mediterranean Holdings is included. |
||
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings. |
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings. |
||
* [[Definition:AXA Investment Managers|AXA Investment Managers]] (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated |
* [[Definition:AXA Investment Managers|AXA Investment Managers]] (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated. |
||
* AXA Investment Managers (until July 1, 2025): Asian joint ventures are consolidated under the equity method. |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=147|p=47}} |
||
====== Accounting standards ====== |
====== Accounting standards ====== |
||
| Line 2,541: | Line 2,572: | ||
=== Glossary === |
=== Glossary === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=148|p=48}} |
||
====== Glossary of financial terms ====== |
====== Glossary of financial terms ====== |
||
* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0% |
* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%. |
||
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders |
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders. |
||
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period |
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period. |
||
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force |
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force. |
||
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow |
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow. |
||
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) |
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). |
||
* Other Revenues: represent premiums and fees collected on activities other than insurance (i.e., banking, services, and asset management activities). |
|||
* New Business Value (NBV): the value of newly issued contracts during the current year, consisting of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period (carried by Life entities, considering expected renewals), (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes, and (vi) minority interests. |
|||
* New Business Value (NBV): the value of newly issued contracts during the current year |
|||
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided. |
|||
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests |
|||
* New Business |
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP. |
||
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes, net of reinsurance. |
|||
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP |
|||
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term, discounted at the reference interest rate and representing the Group share. |
|||
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes |
|||
* Technical experience: consists of the impacts on the [[Definition:Underlying earnings|underlying earnings]] if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses. |
|||
** Operating variance is net of reinsurance |
|||
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance. |
|||
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term |
|||
** PVEP is discounted at the reference interest rate and PVEP is Group share |
|||
* Technical experience: consists of the impacts on the [[Definition:Underlying earnings|underlying earnings]] if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses |
|||
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance |
|||
=== Thank you === |
|||
{{chunk|doc=snjra2xp9r|c=151|p=49}} |
|||
====== Earnings presentation details ====== |
|||
=== Thank you Full Year 2025 Earnings February 26, 2026 === |
|||
Revision as of 17:02, 22 July 2026
| Document info | |
|---|---|
| Document ID | snjra2xp9r |
| Organization | AXA |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document category | Earnings presentation |
| Document name | AXA Full Year 2025 Results Presentation |
| Publication date | 2026-02-26 |
| Language | English |
| Pages | 49 |
| Source | original URL |
| Transcript | wiki page |
| Data | data page |
This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).
Full Year 2025 Earnings Presentation February 26, 2026
Full Year 2025 Earnings
[c. 1; p. 2]
Legal and cautionary statements
- Certain statements in this document are forward-looking, identified by words like "expects," "anticipates," "may," "plan," "target," "would," and "could".
- Statements regarding expected underlying earnings per share (UEPS) growth for 2026 are forward-looking and provide one-off guidance for the last year of the Group’s current strategic plan.
- Forward-looking statements are based on Management’s current views and intentions, are subject to change, and carry known and unknown risks and uncertainties outside AXA’s control that could cause actual results to differ materially.
- AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by law.
- This presentation refers to non-GAAP financial measures (APMs) used by Management for analyzing operating trends, financial performance, and position.
- Non-GAAP financial measures generally lack standardized meaning and may not be comparable to measures used by other companies.
- Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS.
- "Underlying earnings," UEPS, "underlying return on equity," "combined ratio," and "debt gearing" are APMs as defined by ESMA’s guidelines and AMF’s position statement.
- Reconciliations of APMs to IFRS financial statements and their calculation methodologies are provided in AXA’s 2025 Activity Report.
- AXA’s 2025 Activity Report is available on www.axa.com.
- AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to audit completion.
Contents
[c. 2; p. 3]
Presentation contents and speakers
- FY25 Highlights are on p.04.
- Thomas Buberl is the Group CEO.
- FY25 Business Performance is on p.09.
- Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
- FY25 Financial Performance is on p.13.
- Alban de Mailly Nesle is the Group CFO.
FY25 Highlights
[c. 3; p. 4]
Group CEO
- Thomas Buberl is the Group CEO.
Full Year 2025 – Excellent performance
[c. 4; p. 5]
Financial performance highlights
- Revenues: +6% vs. FY24
- Underlying EPS: +8% vs. FY24
- ROE: 16% in FY25
- Solvency II ratio: 224% in FY25
[c. 5; p. 5]
- DPS growth: +8%
- Annual share buyback: EUR 1.25bn
- Confident to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026
[c. 6; p. 5]
Full Year 2025 – Excellent performance
Executing the plan on growth, margin and efficiency
[c. 7; p. 6]
Underlying earnings by FY
| FY24 | FY25 | Change | |
|---|---|---|---|
| Underlying earnings | 8.1 | 8.4 | +6% |
| Underlying earnings excluding AXA IM | +9% |
[c. 8; p. 6]
Organic growth, profitability, and efficiency
- Top line growth: +6% organic.
- Growth balanced across lines: P&C +5%, Life +9%, Health +5%.
- Record profitability with further margin expansion in P&C and L&H.
- Improved efficiency.
- Continued investments in growth and technology for scaling the business.
- Consistent earnings growth while enhancing reserve prudence.
[c. 9; p. 6]
Executing the plan on growth, margin and efficiency
Diversified franchise, well positioned in an attractive industry
Secular trends fueling demand across businesses
[c. 10; p. 7]
Protection gaps and emerging risks
- Protection gaps and emerging corporate risks are secular trends fueling demand across businesses.
- Demographics are driving demand for private retirement and healthcare.
[c. 11; p. 7]
| Segment | Share |
|---|---|
| Life | 33% |
| Health | 17% |
| Large & Specialty | 17% |
| SME & Mid-market | 16% |
| Retail | 17% |
[c. 12; p. 7]
Secular trends fueling demand
- Secular trends are fueling demand across businesses.
Our right to win
[c. 13; p. 7]
Right to win
- Leading brand and high customer NPS
- Strong and diversified distribution
- Technical expertise in pricing and underwriting risks
- Scale offering a cost advantage
[c. 14; p. 7]
Our right to win
Laying the foundation for the next plan
[c. 15; p. 8]
Strategic priorities
- Clear tech and AI roadmap
- Driving efficiency
- Enhancing capital allocation discipline
- Building resilience
- Confidence in sustaining earnings growth
FY25 Business Performance
[c. 16; p. 9]
FY25 Business Performance
- Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
Strong delivery across our businesses
[c. 17; p. 10]
| Gross written premiums | Underlying earnings | |
|---|---|---|
| France (27% of total GWP1) | +6% to €31bn | +7% to €2.2bn |
| Europe (38% of total GWP1) | +6% to €43bn | +9% to €3.5bn |
| AXA XL (17% of total GWP1) | +4% to €19bn | +9% to €1.9bn |
| Asia, Africa & EME-LATAM (18% of total GWP1) | +13% to €20bn | +6% to €1.5bn |
P&C – Strong margins, confidence in sustaining growth
[c. 18; p. 11]
P&C GWP and earnings
- GWP: EUR 58bn
- GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty)
- Underlying earnings: +9% to EUR 5.9bn
[c. 19; p. 11]
Outlook by business segment
| 2025 | Beyond 2025 | |
|---|---|---|
| Retail and SME & Mid-market | Growing volumes while expanding margins | Investing to improve customer retention & expanding distribution footprint |
| AXA XL (Large & Specialty) | Profitable growth with stable margins | Capitalizing on attractive growth opportunities and continued cycle management |
[c. 20; p. 11]
Future strategic focus
- Continued progress on efficiency
- Higher investment income
- Data & AI to further enhance customer experience & technical excellence
[c. 21; p. 11]
P&C – Strong margins, confidence in sustaining growth
L&H – Good momentum, well positioned to capture growth opportunities
[c. 22; p. 12]
GWP by short-term and long-term
| Short-term | |
| Long-term | |
| Total GWP | €57bn |
[c. 23; p. 12]
Underlying earnings
- Underlying earnings +7% to EUR 3.5bn
2025 Beyond 2025
[c. 24; p. 12]
Strategic priorities
- Long-term business: Accelerating net flows in Savings at attractive margins.
- Long-term business: Capturing savings & retirement opportunity, sourcing best asset management products for customers.
- Short-term business: Growing technical results while absorbing Mexico VAT impact.
- Short-term business: Capitalizing on demand for health & protection while further improving margins.
- Focus on cost reduction.
- Increasing penetration of Protection riders in Savings offerings.
- Leveraging AI to reduce claims leakage & improve customer outcomes in Health.
[c. 25; p. 12]
2025 Beyond 2025
FY25 Financial Performance
[c. 26; p. 13]
Group CFO
- Alban de Mailly Nesle is the Group CFO.
P&C – Continued disciplined growth
[c. 27; p. 14]
Currency notation
- All figures are in EUR billion.
GWP & Other Revenues
[c. 28; p. 14]
GWP & other revenues by segment
| Segment | FY24 | FY25 | Change | o/w pricing1 | o/w volume2 |
|---|---|---|---|---|---|
| Commercial lines | 35.8 | +4% | +2% | +2% | |
| AXA XL Reinsurance | 2.6 | +8% | +0.3% | +7% | |
| Retail lines | 19.7 | +7% | +5% | +2% | |
| Total | 56.5 | 58.0 | +5% |
[c. 29; p. 14]
Commercial lines growth drivers
- Continued pricing momentum and volume growth in Mid-market and SME
- Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance
- Growth supported by alternative capital
- Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
[c. 30; p. 14]
GWP & Other Revenues
P&C – Delivering further margin expansion while enhancing reserve prudence
Combined ratio
[c. 31; p. 15]
Combined ratio
| FY24 | FY25 | |
|---|---|---|
| Combined ratio | 91.0% | 90.6% |
| Undiscounted CY loss ratio (ex Nat Cat) | 67.4% | 67.0% |
| Expense ratio | 25.0% | 24.8% |
| Nat Cat | 3.8% | 3.4% |
| Prior year reserve development | -1.6% | -1.1% |
| Discount | -3.6% | -3.5% |
[c. 32; p. 15]
Combined ratio drivers
- Undiscounted current year loss ratio improved, excluding Nat Cat.
- Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing.
- AXA XL Insurance margins stable at attractive levels due to disciplined cycle management.
- Expense ratio improved due to efficiency measures, while investing in growth initiatives and technology.
[c. 33; p. 15]
Nat Cat and reserve development
- Nat Cat charges were below the normalized load.
- Lower reliance on prior year reserve development.
- Reserve prudence enhanced during a favorable year.
P&C – Earnings growth from higher underwriting and financial result
[c. 34; p. 16]
P&C earnings overview
- P&C earnings increased by EUR 0.2bn to EUR 4.2bn.
- This growth was driven by higher underwriting results and a higher financial result.
[c. 35; p. 16]
Underlying earnings by step
| Step | Value |
|---|---|
| FY24 | 5,510 |
| Volume growth ( Underwriting result1) | +292 |
| Margin improvement | +189 |
| Investment income ( Financial result) | +435 |
| Insurance finance expenses | -235 |
| Tax | -169 |
| Affiliates, FX & other | -150 |
| FY25 | 5,872 |
[c. 36; p. 16]
P&C earnings growth drivers
- P&C earnings grew +9%.
- Growth driven by a better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence.
- Increase in investment income reflects higher volumes and better reinvestment yields on fixed income assets.
- Higher unwind of discount of claims reserves, in line with guidance.
- Unfavorable forex impact notably due to USD depreciation vs. EUR.
[c. 37; p. 16]
P&C – Earnings growth from higher underwriting and financial result
[c. 38; p. 17]
- Life & Health premiums: EUR 49.1bn (+7% LFL)
- Life & Health net flows: EUR +0.2bn
[c. 39; p. 17]
Life GWP & other revenues by lines of business
| FY24 | FY25 | Growth | |
|---|---|---|---|
| Total | 34.5 | 37.5 | +9% |
| Protection | 17.3 | +11% | |
| Unit-Linked | 9.3 | +13% | |
| Capital light G/A | 9.0 | +7% | |
| Traditional G/A | 1.9 | -7% |
[c. 40; p. 17]
Health GWP & other revenues by individual and group
| FY24 | FY25 | Growth | |
|---|---|---|---|
| Total | 17.5 | 19.0 | +5% |
| Individual | 10.5 | +6% | |
| Group | 8.5 | +4% |
[c. 41; p. 17]
Net flows by segment
| Segment | Net flows |
|---|---|
| Protection | +4.9 |
| Health | +2.7 |
| Unit-Linked | +1.5 |
| Capital light G/A | +1.2 |
| Traditional G/A | -5.0 |
[c. 42; p. 17]
[c. 43; p. 17]
Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
[c. 44; p. 18]
PVEP by business line
| FY24 | FY25 | |
|---|---|---|
| Protection & Health | 31.4 | |
| Unit-Linked | 8.5 | |
| Capital-light G/A | 7.8 | |
| Traditional G/A | 1.7 | |
| Total | 50.9 | 49.4 |
| Change | -2% | |
| Protection & Health change | -4% | |
| Unit-Linked change | +18% | |
| Capital-light G/A change | -10% | |
| Traditional G/A change | -10% | |
[c. 45; p. 18]
NB CSM (pre-tax) by FY
| FY24 | FY25 |
|---|---|
| 2.2 | 2.2 |
| +3% | |
[c. 46; p. 18]
NBV (post-tax) by FY
| FY24 | FY25 |
|---|---|
| 2.3 | 2.2 |
| stable | |
| NBV margin 4.4% | 4.5% |
[c. 47; p. 18]
Life & Health performance drivers
- PVEP was impacted by higher interest rates on discounting, despite strong growth in Life volumes.
- NB CSM was driven by robust Savings & Protection sales; reported growth was impacted by higher interest rates for discounting of future profits.
- NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
[c. 48; p. 18]
Reporting basis
- All changes are at constant scope and FX.
Life & Health – Growth in new business driving Normalized CSM growth
[c. 49; p. 19]
Financial Metrics
- All figures are in EUR billion.
Contractual Service Margin rollforward
[c. 50; p. 19]
Contractual Service Margin rollforward (In Euro billion)
| FY24 | New business CSM | Underlying return on in-force | CSM release | Economic variance | Operating variance | Affiliates, FX & other | FY25 |
|---|---|---|---|---|---|---|---|
| 33.6 | +2.2 | +1.3 | -3.0 | +0.6 | -0.3 | -1.4 | 33.0 |
| Normalized CSM growth +2% | |||||||
[c. 51; p. 19]
CSM breakdown by business line
[c. 52; p. 19]
Normalized CSM growth and drivers
- Normalized CSM increased by +2%
- CSM release growth reflects better margins
- New business CSM growth was impacted by higher rates
- Economic variance reflects government spreads tightening and positive equity market returns
- Operating variance driven by better margins and net flows, offset by a reduction in the duration of Group Life business in Switzerland
- FX impact mainly from JPY and HKD depreciation
[c. 53; p. 19]
Contractual Service Margin rollforward
Life & Health – Strong momentum in both short-term and long-term business
[c. 54; p. 20]
Life & Health gross revenues
- Gross revenues: EUR 32,009m in 2023 (reported)
- France: EUR 10,009m
- Europe: EUR 10,009m
- AXA XL: EUR 1,000m
- International: EUR 1,000m
- Asia: EUR 10,000m
- Other: EUR 0m
Underlying Earnings +7%
[c. 55; p. 20]
Underlying Earnings waterfall by Step
| Step | Value |
|---|---|
| FY24 | 3,323 |
| Short-term technical margin | +60 |
| Long-term result incl. CSM release | +156 |
| Financial result | -11 |
| Tax, FX and others | -27 |
| FY25 | 3,501 |
[c. 56; p. 20]
FY24 vs FY25 Underlying Earnings breakdown (In Euro million)
| FY24 | FY25 | |
|---|---|---|
| Short-term technical margin | 415 | 479 |
| Long-term result incl. CSM release | 2,680 | 2,804 |
| Financial result | 975 | 946 |
| Tax & others | -748 | -728 |
[c. 57; p. 20]
Underlying Earnings by Business Line
- Life underlying earnings: EUR 2.7bn (prior: EUR 2.6bn), +4% vs. FY24
- Health underlying earnings: EUR 0.8bn (prior: EUR 0.7bn), +17% vs. FY24
[c. 58; p. 20]
Technical Margin and Long-Term Results
- Strong short-term technical margin due to underwriting and claims initiatives
- Impact of legislative change on recoverability of value added tax in Mexico: -EUR 0.1bn
- Higher long-term results from +8% increase in CSM release
- Increase in CSM release reflects growth in reserve base, including from favorable equity market performance, and better margins
[c. 59; p. 20]
Underlying Earnings +7%
Growth in net income reflecting higher earnings & the gain from the sale of AXA IM
[c. 60; p. 21]
Net income by business line
| FY24 | FY25 | Change | |
|---|---|---|---|
| Property & Casualty | 5.5 | 5.9 | +9% |
| Life & Health | 3.3 | 3.5 | +7% |
| Asset Management | 0.4 | 0.2 | -57% |
| Holdings & other | -1.2 | -1.2 | - |
| Underlying earnings | 8.1 | 8.4 | +6% |
| Non-financial flows | -0.5 | +2.1 | |
| o/w capital gains from AXA IM disposal | - | +2.2 | |
| Financial flows (incl. RCG) | +0.3 | -0.7 | |
| Net income | 7.9 | 9.8 | +26% |
[c. 61; p. 21]
Underlying earnings and holding costs
- Underlying earnings showed strong performance from insurance businesses.
- Holding cost was stable and is expected to remain at the current level in 2026.
[c. 62; p. 21]
Net income drivers
- Net Income was higher, mainly reflecting higher underlying earnings and the gain from the sale of AXA IM.
- Lower financial flows reflected an unfavorable forex impact.
[c. 63; p. 21]
- Underlying earnings per share are presented in EUR.
[c. 64; p. 21]
| FY24 | FY25 | Change |
|---|---|---|
| 3.59 | 3.86 | +8% |
[c. 65; p. 21]
Underlying EPS growth drivers
- Underlying EPS growth included +6% from earnings growth.
- Underlying EPS growth included +3% from capital management.
- Underlying EPS growth included -2% from forex.
- Underlying EPS growth included -1% from temporary earnings dilution due to the timing of the anti-dilutive share buyback related to the AXA IM sale.
[c. 66; p. 21]
[c. 67; p. 22]
- Shareholders' Equity is presented in EUR billion.
[c. 68; p. 22]
| FY24 | HY25 | FY25 | |
|---|---|---|---|
| SHE (excl. OCI) | 58.0 | 52.7 | 54.0 |
| Net OCI | -8.1 | -7.2 | -6.8 |
| Shareholders' Equity | 49.9 | 45.5 | 47.2 |
| SHE (excl. OCI & undated subordinated debt) | 53.2 | 47.0 | 49.4 |
| Debt gearing | 20.6% | 23.4% | 22.3% |
| Underlying ROE | 15.2% | 17.5% | 16.0% |
[c. 69; p. 22]
| FY24 to FY25 | HY25 to FY25 | |
|---|---|---|
| Opening Shareholders' equity | 49.9 | 45.5 |
| Change in Net OCI | 1.3 | 0.4 |
| Net income for the period | 9.8 | 5.9 |
| Dividend | -4.6 | - |
| Annual share buyback | -1.2 | - |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 | -3.5 |
| Undated subordinated debt (including interest charges) | -0.3 | -1.2 |
| Forex | -3.5 | -0.1 |
| Other | -0.6 | 0.3 |
| Closing Shareholders' equity | 47.2 | 47.2 |
Higher organic cash remittance and robust cash position at Holding
[c. 70; p. 23]
Currency notation
- All figures are in EUR bn.
Net Cash Remittance
[c. 71; p. 23]
Net Cash Remittance
| FY24 | FY25 | |
|---|---|---|
| Proceeds related to in-force treaties2 | 0.6 | |
| Ordinary remittance | 7.1 | 7.5 |
| Total | 7.7 | 7.5 |
| Remittance ratio1 | 82% | 82% |
[c. 72; p. 23]
Net Cash Remittance
| FY24 Cash position | 4.0 |
|---|---|
| Net cash remittance from subsidiaries | +7.5 |
| Dividend | -4.6 |
| Annual share buyback | -1.2 |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 |
| Holding costs and interest expenses | -1.3 |
| Change in net debt | +1.6 |
| M&A and other | +3.1 |
| FY25 Cash position | 5.6 |
Solvency II at 224%
[c. 73; p. 24]
- Foreseeable dividends: EUR -4.8bn
- Provision for annual share buyback for 2026: EUR -1.25bn
[c. 74; p. 24]
Eligible Own Funds (EOF) / Solvency Capital Requirement (SCR) / Solvency II ratio bridge FY24–FY25
| FY24 | Regulatory & model changes | Normalized capital generation | Operating variance | Economic variance & FX | Dividend & annual share buyback | Management actions, debt & other | FY25 | |
|---|---|---|---|---|---|---|---|---|
| Eligible Own Funds (EOF) | 55.9 | +0.2 | +8.8 | -0.4 | -2.1 | -6.0 / -0.1 | 56.4 | |
| Solvency II ratio | 216% | +0pt | +28pts | -1pt | +4pts | -24pts | +2pts | 224% |
| Solvency Capital Requirement (SCR) | 25.9 | 0.0 | +0.6 | 0.0 | -1.2 | 0.0 | -0.2 | 25.2 |
Key sensitivities
[c. 75; p. 24]
Solvency II ratio
- Solvency II ratio as of December 31, 2025: 224%
[c. 76; p. 24]
Impact by sensitivity
| Sensitivity | Impact |
|---|---|
| Interest rate +50bps | +2 pts |
| Interest rate -50bps | -1 pt |
| Corporate spreads +50bps | -1 pt |
| Euro Sovereign spreads +50bps1 | -7 pts |
| Credit migration2 | -4 pts |
| Listed Equity (excl. PE & Infra) +25% | -1 pt |
| Listed Equity (excl. PE & Infra) -25% | +2 pts |
| PE & Infra +25% | +14 pts |
| PE & Infra -25% | -19 pts |
| Inflation swap curve +50bps | -5 pts |
Solvency II – impact of the end of grandfathering period and Solvency II revision
[c. 77; p. 25]
Solvency II Ratio and Capital Impacts
- Solvency II Ratio as of 31/12/2025: 224%
- Impact of the end of the grandfathering period on January 1, 2026: -10pts, reducing the ratio to 215%
- EUR 2.4bn of grandfathered debt will no longer be eligible as capital from January 1, 2026
- Impact of Solvency II revision, expected to come into effect in 1Q27: +17pts
- No change expected in organic capital generation
- Additional capital flexibility
Conclusion
[c. 78; p. 26]
Group CEO
- Thomas Buberl is the Group CEO.
Conclusion
[c. 79; p. 27]
Business performance and outlook
- Record results were achieved, at the top end of the target range, while enhancing reserve prudence.
- All businesses are
Q&A
[c. 80; p. 28]
Date
- February 26, 2026
AXA Investor Relations – Keep in touch
Meet our management
[c. 81; p. 29]
Investor calendar
- March: Roadshows in Europe and US
- May 5: 1Q25 Activity Indicators in Paris
- June 2: BNP Paribas Exane CEO Conference in Paris
- June 2-4: Goldman Sachs European Financials Conference in Zurich
- July 31: HY26 Earnings Release in Paris
- September 21: AXA Investor Day in London
Contact us
[c. 82; p. 29]
Investor Relations contact
- Investor Relations contact number: +33 1 40 75 48 42.
- Investor Relations email: investor.relations@axa.com.
Follow us
[c. 83; p. 29]
Website information
- AXA's website is www.axa.com.
Appendices
Contents
[c. 84; p. 31]
Additional disclosures
- Debt and Invested Assets are on p.31.
- Additional P&C disclosures are on p.36.
- Additional IFRS17 disclosures are on p.41.
Gross financial debt and maturity breakdown as of December 31st, 2025
[c. 85; p. 32]
Gross financial debt and maturity breakdown as of December 31st, 2025
Theme: Gross financial debt and
Gross financial debt Contractual maturity breakdown
[c. 86; p. 32]
Debt gearing
- Debt gearing was 20.6% (prior: 22.3%).
[c. 87; p. 32]
Gross financial debt by tier
| FY24 | FY25 | Jan 1st 2026 | |
|---|---|---|---|
| Tier 1 | 4.8 | 4.6 | 3.2 |
| Tier 2 | 10.8 | 12.2 | 11.3 |
| Senior debt | 3.5 | 3.5 | 5.8 |
| Total | 19.2 | 20.3 | 20.3 |
[c. 88; p. 32]
Debt maturity and types
- The grandfathering period ends on January 1, 2026.
- EUR 0.4bn will be redeemed in January 2026.
- Debt types include Tier 1, Tier 2, and Senior debt.
[c. 89; p. 32]
Senior debt, Tier 2, Tier 1 by contractual maturity
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated | |
|---|---|---|---|---|---|---|---|---|---|
| Senior debt | 0.9 | 1.5 | 0.5 | ||||||
| Tier 2 | 0.5 | 0.7 | 10.8 | 4.6 | |||||
| Tier 1 | 0.7 |
o/w Grandfathered debt (Contractual maturity breakdown)
[c. 90; p. 32]
o/w Grandfathered debt (Contractual maturity breakdown)
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated | |
|---|---|---|---|---|---|---|---|---|---|
| Tier 1 | - | - | - | - | - | - | - | - | 1.4 |
| Tier 2 | - | - | - | - | - | 0.7 | - | 0.2 | - |
Economic maturity breakdown
[c. 91; p. 32]
Economic maturity breakdown (In Euro billion)
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated | |
|---|---|---|---|---|---|---|---|---|---|
| Senior debt | 1.5 | 0.5 | |||||||
| Tier 2 | 0.1 | 2.4 | 0.5 | 2.0 | 0.4 | 6.4 | 0.7 | ||
| Tier 1 | 0.1 | 0.1 | 0.9 | 4.0 |
o/w Grandfathered debt (Economic maturity breakdown)
[c. 92; p. 32]
Grandfathered debt by economic maturity and tier
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated | |
|---|---|---|---|---|---|---|---|---|---|
| Tier 1 | - | 0.1 | - | 0.1 | - | - | 0.4 | - | 0.8 |
| Tier 2 | - | - | - | - | - | 0.7 | 0.2 | - | - |
General Account Invested Assets
[c. 93; p. 33]
General Account invested assets
- FY25 Total General Account invested assets
- Duration gap at -0.4 year
[c. 94; p. 33]
FY25 Total General Account invested assets: Euro 450 billion
| Fixed income | 77% |
| Real estate | 9% |
| Infrastructure equity | 2% |
| Listed equities | 2% |
| Private equity and hedge funds | 5% |
| Cash | 4% |
| Policy loans | 0% |
[c. 95; p. 33]
Invested assets (100%) In Euro billion
| FY25 | % | |
|---|---|---|
| Fixed income | 345 | 77% |
| o/w Government bonds | 167 | 37% |
| o/w Corporate bonds and loans | 121 | 27% |
| o/w Other fixed income 1 | 56 | 13% |
| Real estate | 41 | 9% |
| Infrastructure equity | 10 | 2% |
| Listed equities 2 | 10 | 2% |
| Private equity and hedge funds 3 | 23 | 5% |
| Cash | 19 | 4% |
| Policy loans | 2 | 0% |
| Total Insurance Invested Assets 4 | 450 | 100% |
Structured and Private Credit assets
[c. 96; p. 34]
Structured and Private Credit assets
| Invested assets (100%) In Euro billion |
FY25 | % of total G/A1 portfolio | Comments |
|---|---|---|---|
| Residential Mortgages | 16 | 4% | - €6bn Dutch mortgages, NHG guaranteed - €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
| CLO & ABS | 25 | 6% | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
| Infrastructure debt | 8 | 2% | - Skewed towards resilient industries (Telecom, Utilities, Transport) |
| CRE debt | 8 | 2% | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
| Mid-Market lending | 10 | 2% | - Strong diversification with €8m average ticket - Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation |
| Other | 2 | 0% | |
| Total Structured and Private Credit Assets | 69 | 15% | o/w 54% participating |
Investment portfolio – Fixed Income reinvestment
FY25 Fixed Income Reinvestment
[c. 97; p. 35]
FY25 fixed income reinvestment allocation
- EUR 57bn in fixed income reinvestment
- Government bonds & related: 32% of reinvestment, average rating AA
- Investment grade credit: 40% of reinvestment, average rating A
- ABS/CLO/IG fund financing: 21% of reinvestment
- Below investment grade credit: 7% of reinvestment
FY25 Fixed Income Reinvestment Yield
[c. 98; p. 35]
FY25 Fixed Income Reinvestment Yield
| Public fixed income1 | Private & Structured fixed income2 | Total fixed income |
|---|---|---|
| 3.5% | 4.7% | 3.9% |
[c. 99; p. 35]
Fixed income investment details
- EUR 57bn fixed income invested at 3.9%
- Average duration of 9 years
- Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY)
- Gradual shift from alternative total return assets to Private & Structured credit
[c. 100; p. 35]
FY25 Fixed Income Reinvestment Yield
Contents
[c. 101; p. 36]
Additional disclosures
- Debt and Invested Assets are detailed on p.31.
- Additional P&C disclosures are provided on p.36.
- Additional IFRS17 disclosures are available on p.41.
AXA XL Insurance – Large Commercial & Specialty business
Well diversified across lines of business and geographies
[c. 102; p. 37]
FY25 GWP by line of business
- FY25 GWP by line of business: USD 19bn
- Casualty: 35%
- Property: 29%
- Specialty: 19%
- Professional lines: 17%
[c. 103; p. 37]
FY25 GWP by geography
Leading market positions across lines
[c. 104; p. 37]
Leading market positions
- Top 3 globally
- Multinational Programs
- Marine
- Fine Art & Specie
Managing the cycle to deliver consistent profitability
[c. 105; p. 37]
Commercial lines performance by segment
- Bubble chart axes: Ex-price growth (%) (x-axis) and Profitability (y-axis).
- Segments shown in the bubble chart:
- Property: high profitability, high ex-price growth
- Specialty
- Casualty
- Professional lines: lower profitability, lower ex-price growth
[c. 106; p. 37]
Managing the cycle to deliver consistent profitability
P&C – Focus on Reserves
Claims reserves ratio
[c. 107; p. 38]
Claims reserves ratio definition
- Claims reserves ratio is defined as Net undiscounted claims reserves divided by Net earned premiums.
[c. 108; p. 38]
Claims reserves ratio
| FY18 | FY19 | FY20 | FY21 | FY22 (IFRS4) | FY22 (IFRS17) | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|
| Claims reserves ratio | 179% | 185% | 193% | 188% | 189% | 198% | 195% | 180% | 175% |
Technical reserves ratio
[c. 109; p. 38]
Net undiscounted technical reserves ratio
- The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums.
[c. 110; p. 38]
Technical reserves ratio
| FY18 | FY19 | FY20 | FY21 | FY22 (IFRS4) | FY22 (IFRS17) | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|
| Technical reserves ratio | 213% | 227% | 233% | 226% | 227% | 234% | 232% | 216% | 210% |
P&C – 2026 Simplified Group Nat Cat Reinsurance Program
[c. 111; p. 39]
Currency basis
- All figures are in Euro.
[c. 112; p. 39]
Capacity & Retention by peril
| EU Windstorm | Europe Flood | Europe Earthquake | NA Hurricane | NA Earthquake | Per other perils3 | Reinsurance segment (illustrative) — Alternative Capital & Cat Bonds | |
|---|---|---|---|---|---|---|---|
| Capacity | 4.0bn | 2.1bn | 2.1bn | 1.2bn | 1.2bn | ||
| Retention | 600m | 450m | 400m | 600m2 | 600m2 | 400m |
[c. 113; p. 39]
2026 Simplified Group Nat Cat Reinsurance Program
- Retention levels are expected to remain stable in 2026, consistent with 2025 levels.
[c. 114; p. 39]
P&C – 2026 Simplified Group Nat Cat Reinsurance Program
P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026
[c. 115; p. 40]
Nat Cat cost deviation
- Nat Cat cost deviation is presented in EUR billion, net of reinsurance.
Group underlying earnings deviation to average Nat Cat charges in 2026
[c. 116; p. 40]
Net of reinsurance
- The data is presented both net of reinsurance, post-tax, and net of reinsurance, pre-tax.
[c. 117; p. 40]
Deviation by scenario and percentile
| Scenario | Percentile | Deviation |
|---|---|---|
| 1/20y more severe | 95th | €-1.2bn |
| 1/10y more severe | 90th | €-0.8bn |
| 1/5y more severe | 80th | €-0.4bn |
| Median | 50th | €+0.1bn |
| 1/5y less severe | 20th | €+0.5bn |
| 1/10y less severe | 10th | €+0.7bn |
| 1/20y less severe | 5th | €+0.8bn |
[c. 118; p. 40]
Nat Cat charges deviation
- Negative deviation in approximately 40% of cases for more severe years.
- Positive deviation in approximately 60% of cases for less severe years.
Average Expected Nat Cat charges
[c. 119; p. 40]
Amount & Estimated impact on GEP by year
| 2025 | 2026 | |
|---|---|---|
| Amount (€bn) | 2.6 | 2.7 |
| Estimated impact on GEP | ca. 4.5% | ca. 4.5% |
Contents
[c. 120; p. 41]
Additional disclosures
- Additional disclosures include Debt and Invested Assets on p.31.
- Additional P&C disclosures are on p.36.
- Additional IFRS17 disclosures are on p.41.
P&C – Margin Analysis
Technical Result
[c. 121; p. 42]
Pre-tax technical result
- Pre-tax technical result in EUR million.
[c. 122; p. 42]
Current Accident Year Undiscounted Technical Margin by FY25
| FY25 | Change | |
|---|---|---|
| Current Accident Year Undiscounted Technical Margin | 2,778 | +707 |
[c. 123; p. 42]
Gross Earned Premiums and Current Accident Year Undiscounted Combined Ratio
| Gross Earned Premiums | 57,656 | +6% |
| Current Accident Year Undiscounted Combined Ratio | 95.2% | -1.0pt |
| o/w Nat Cats | 3.4% | -0.4pt |
[c. 124; p. 42]
Current Accident Year Discounting
| FY25 | Change | |
|---|---|---|
| Current Accident Year Discounting | 2,009 | +115 |
| Discounting Ratio (in Combined Ratio points) | -3.5% | +0.0pt |
| Current Accident Year Net Claims reserves | €19.0bn | |
| Duration | 4.0 years | |
| Current Accident Year Discount rate | 2.8% |
[c. 125; p. 42]
Prior Years' Reserve Development (PYD)
| FY25 | Change | |
|---|---|---|
| Prior Years' Reserve Development (PYD) | 622 | -341 |
| PYD ratio | -1.1% | +0.7pt |
[c. 126; p. 42]
FY25 sensitivity to Current Accident Year discount rate changes
| +25bps | -25bps |
|---|---|
| €+0.2bn | €-0.2bn |
Financial Result
[c. 127; p. 42]
Pre-tax results
- All figures are in EUR million (pre-tax).
[c. 128; p. 42]
Investment Income
| FY25 | Change | |
|---|---|---|
| Investment Income | 3,988 | +435 |
| FY25 Average Assets | €115bn | |
| Asset book yield | 3.5% | |
| FY25 Reinvestment yield1 | 4.3% |
[c. 129; p. 42]
Insurance finance expenses
| FY25 | Change | |
|---|---|---|
| Insurance Finance Expenses | -1,358 | -235 |
| FY24 Reserves at locked-in rate | €71bn | |
| Liability book yield | 1.9% |
[c. 130; p. 42]
2026e Insurance Finance Expenses (pre-tax) by change in 2025 current AY Discount
| +25bps | -25bps |
|---|---|
| ~ €-50m | ~€+50m |
[c. 131; p. 42]
Underlying earnings before tax, tax, affiliates, minority interests & other, and underlying earnings
| FY25 | Change | |
|---|---|---|
| Underlying Earnings before tax | 8,040 | +681 |
| Tax | -2,060 | -169 |
| Affiliates, Minority interests & Other | -108 | -10 |
| Underlying Earnings | 5,872 | +501 |
| Growth vs. FY24 (at constant FX) | +9% |
L&H – Margin Analysis
[c. 132; p. 43]
Scope impact
- Includes scope impact.
Technical Result
[c. 133; p. 43]
Pre-tax technical result
- Pre-tax technical result (in EUR million):
[c. 134; p. 43]
Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio
| FY25 | Change | |
|---|---|---|
| Short-term Technical Margin | 479 | +60 |
| Gross Earned Premiums | 17,416 | +10% |
| All Year Combined Ratio | 97.2% | -0.1pts |
[c. 135; p. 43]
Laya recapture
- Includes recapture of Laya.
[c. 136; p. 43]
Long-term Technical Margin by CSM release and Technical experience
| FY25 | Change | |
|---|---|---|
| Long-term Technical Margin | 2,804 | +156 |
| CSM release | 2,954 | +215 |
| Technical experience | -150 | -58 |
[c. 137; p. 43]
FY25 CSM by interest rates, sovereign spreads, corporate spread, equities
| Baseline | 33.3 |
|---|---|
| Interest rates +50bps | -0.8 |
| Interest rates -50bps | 0.6 |
| Sovereign spreads +50bps | -1.9 |
| Sovereign spreads -50bps | 1.9 |
| Corporate spread +50bps | -0.8 |
| Corporate spread -50bps | 0.7 |
| Equities +25% | 1.8 |
| Equities -25% | -2.2 |
Financial Result
[c. 138; p. 43]
Pre-tax result by segment
- Pre-tax result: EUR 7,604m
- France: EUR 2,000m
- Europe: EUR 2,000m
- AXA XL: EUR 1,500m
- Asia: EUR 1,000m
- International: EUR 500m
- AXA IM: EUR 200m
- Other: EUR 400m
[c. 139; p. 43]
Investment income (non-VFA only)
| FY25 | Change | |
|---|---|---|
| Investment Income (non-VFA only) | 2,484 | -1 |
| FY25 Average Assets | €98bn | |
| Asset book yield | 2.5% | |
| FY25 Reinvestment yield1 | 3.8% |
[c. 140; p. 43]
Insurance Finance Expenses (non-VFA only)
| FY25 | Change | |
|---|---|---|
| Insurance Finance Expenses (non-VFA only) | -1,538 | -9 |
| FY24 Reserves at locked-in rate | €62bn | |
| Liability book yield | 2.5% |
[c. 141; p. 43]
Underlying Earnings before tax, Tax, Affiliates, Minority interests & Other, Underlying Earnings
| FY25 | Change | |
|---|---|---|
| Underlying Earnings before tax | 4,229 | +205 |
| Tax | -800 | 65 |
| Affiliates, Minority interests & Other | 72 | -51 |
| Underlying Earnings | 3,501 | +219 |
| Growth vs. FY24 (at constant FX) | +7% |
Contents
[c. 142; p. 44]
Additional disclosures
- Additional disclosures include Debt and Invested Assets.
- Additional disclosures include P&C disclosures.
- Additional disclosures include IFRS17 disclosures.
Expanding AXA's role in society: AXA for Progress Index
[c. 143; p. 45]
2025 Result by As a GLOBAL INVESTOR, As a GLOBAL INSURER, As a COMPANY
| As a GLOBAL INVESTOR | As a GLOBAL INSURER | As a COMPANY | |||
|---|---|---|---|---|---|
| Target | 2025 Result | Target | 2025 Result | Target | 2025 Result |
| €5bn2 in climate transition financing per year | €6.4bn | €6bn3 in P&C GWP to support transition underwriting (cumulative 2024-2026) | €4.6bn | >80,0006(footnote: Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.) AXA Group employees trained on climate adaptation by 2026 | 46,420 |
| >€500m2 in community resilience financing per year | >20,0004 climate adaptation solutions & services (cumulative 2024-2026) Target revised in 2025 | 19,698 Cumulative 2024-2025 | Contribute to Net-Zero -50%7(footnote: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.) by 2030 in absolute carbon emissions and offset of residual emissions8(footnote: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).) | -64% Reduction against 2019 | |
| €1.4bn | >20m5(footnote: Low-income to mass market segments in emerging markets and modest income segments in mature markets.) inclusive insurance customers by 2026 | 20.6m | 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 | 56% | |
Sustainability Performance & Ratings
[c. 144; p. 46]
Sustainability ratings
- S&P Global: 97th percentile in Dow Jones Best-in-Class Europe & World indices for 2025.
- MSCI: AAA score for 2025.
- CDP: B score for 2025.
- Morningstar Sustainalytics: ESG Risk Rating of 17.0 (Low risk) for 2025.
- FTSE Russell: 4.3/5 score in FTSE4Good Index Series for 2025.
[c. 145; p. 46]
Sustainability Performance & Ratings
Scope
[c. 146; p. 47]
Scope of activities by geography and segment
- France: includes insurance activities, banking activities, and holding.
- Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxembourg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities).
- AXA XL: includes insurance and reinsurance activities and holding.
- Asia, Africa & EME-LATAM:
- Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated.
- Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, underlying earnings, and net income.
- Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), Egypt (insurance activities and holding) are fully consolidated.
- EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated.
- EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income.
- AXA Mediterranean Holdings is included.
- Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings.
- AXA Investment Managers (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated.
- AXA Investment Managers (until July 1, 2025): Asian joint ventures are consolidated under the equity method.
[c. 147; p. 47]
Accounting standards
- All comparative figures going back to 2023 are under IFRS17/9 accounting standards, effective January 1, 2023, unless otherwise specified.
- Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4.
Glossary
[c. 148; p. 48]
Glossary of financial terms
- Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%.
- Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders.
- CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period.
- Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force.
- Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow.
- Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business).
- Other Revenues: represent premiums and fees collected on activities other than insurance (i.e., banking, services, and asset management activities).
- New Business Value (NBV): the value of newly issued contracts during the current year, consisting of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period (carried by Life entities, considering expected renewals), (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes, and (vi) minority interests.
- New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided.
- New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP.
- Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes, net of reinsurance.
- Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term, discounted at the reference interest rate and representing the Group share.
- Technical experience: consists of the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses.
- Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance.